| 2004-01-22 16:07:00 |
Appendix 3B - Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b3275d43873ea7913cc120025f79d89 |
|
| 2004-02-05 09:42:00 |
Work begins on Bird Flu Vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/faeb97da6eb2985fcf60137fb515b75e |
|
| 2004-02-26 19:43:00 |
Half Year Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f51e3cb34784888be9317d9e1002ce80 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2004-02-26 19:47:00 |
Half Yearly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b249b0284f0b35f681869323e2dc487 |
|
| 2004-03-26 16:21:00 |
Appendix 3B - Conversion of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16c0d237e022e4d5d7bf0d004877508c |
|
| 2004-04-29 10:41:00 |
New Vaccine for Major Pig Disease Complete Successful Trials |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c09e4f69498f69579e08ae7da0252bc1 |
|
| 2004-04-30 13:41:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3473c3410a7089a33cfa3196b5151484 |
Commitments Test Entity - Third Quarter Report
|
| 2004-05-20 13:09:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5a24836c0018aec5200f127b602a36c |
|
| 2004-05-20 15:47:00 |
Licenses New Technology for Pig Gastrointestinal Diseases |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3f1e6a06746587f57d65f81e53c351bb |
|
| 2004-06-09 18:31:00 |
Securities Ceasing Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/afcc029b68f4a8d12e577c0a57eab3e5 |
|
| 2004-06-22 11:54:00 |
Development Plans -E. coli Treatment for Pigs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5115be8308e741c27794d24489c27ebe |
|
| 2004-06-25 10:43:00 |
Appendix 3B - Conversion of CPS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33ac202a89e50484dbab196aefea576b |
|
| 2004-07-01 15:46:00 |
Appendix 3B - conversion of options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b5851337a5823e208de78fe0fb13316a |
|
| 2004-07-05 11:41:00 |
Details for an Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac973d693b12dda6d7aaf0cb9804f210 |
Notice of Meeting - Other
|
| 2004-07-13 14:36:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e0038231d6fb540213ea7d5f3f4b5f2 |
|
| 2004-07-29 12:15:00 |
Updated Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/adbd5da68429c7ec4998e356ddabb350 |
|
| 2004-07-29 17:38:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ddff4a3870b183d17566e70f41a24920 |
Commitments Test Entity - Fourth Quarter Report
|
| 2004-08-04 11:17:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aabe9c05e419a7be01270310d86be0a0 |
Ceasing to be a substantial holder
|
| 2004-08-05 10:26:00 |
Successful Trial achieves 7% growth gain in poultry |
1 |
https://app.sharelinktechnologies.com/announcement/asx/54912631c0ae19a80c89fb606f9c86ff |
|
| 2004-08-13 10:37:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa9f3f8f0e2043278fd85ff8359ce0eb |
Ceasing to be a substantial holder
|
| 2004-08-24 13:03:00 |
Avian Influenza Vaccine to Begin Efficacy Trials |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1a9f84cd1e690a1ba7a8a4e89b66aa8 |
|
| 2004-08-31 14:57:00 |
Preliminary Final Report & Full Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d53afa04e35fc0144bedee19af5407bb |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2004-09-02 18:22:00 |
Appendix 3B - Conversion of Unlisted Options/S 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f1ef8dfa7122634a4a7d1e727f8e0d6 |
|
| 2004-09-16 09:20:00 |
Receptor Mimic Technology to be Commercialised for Humans |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5de2c5dddf8bf363f943390badf75b74 |
|
| 2004-09-16 09:22:00 |
Receptor Mimic Technology to be Commercialised for Humans |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cc161638983c5502214f4db4f05296da |
|
| 2004-09-16 09:26:00 |
Secures Receptor Mimic Technology for all Animal Species |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a3d3865281a7c136ce8a5471e4bacd3 |
|
| 2004-10-01 12:14:00 |
Presentation to the Australian Biotech Expo |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0779746852b639baafd57c0e5a615af |
|
| 2004-10-07 10:55:00 |
Results of RMT Pilot Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2577c8d68c41070f0b9efafe3aec955c |
|
| 2004-10-18 14:00:00 |
Avian Influenza Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd699ed4f420153287857a271b74c3a8 |
|
| 2004-10-25 11:13:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1426e1cbee21f458c63fbf63ee0e92fc |
Notice of Annual General Meeting
|
| 2004-10-25 11:13:00 |
2004 Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fcaf7eeab530454d0b33fc0e43ecce62 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2004-10-25 11:18:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6fb27187c2eb943a7364ab80b222c670 |
Commitments Test Entity - First Quarter Report
|
| 2004-11-04 13:34:00 |
Awarded Grant for Avian Influenza Vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0805fedef4970ff38426c563e67d2fcd |
|
| 2004-11-08 09:20:00 |
New Appointments strengthen product commercialisation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebdd1b38c01a69efffda4aad9d4f546f |
Company Administration - Other
|
| 2004-11-10 13:04:00 |
PRRS Pig Vaccine Successsfully Moves into Product Dev. Phase |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5e6d7e62b735288c2156dbf692219f89 |
|
| 2004-11-15 14:22:00 |
Successful Poultry Productivity Enhancer Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7df83dd74ce759510630a7f719b9b380 |
|
| 2004-11-16 15:43:00 |
Key Patent Granted in Japan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7fae6a4391857ef6cc306344983d6bce |
|
| 2004-11-17 13:06:00 |
Bird Flu Vaccine Back on Track |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6938c9be7067f8d54bbf0ba3e06c2818 |
|
| 2004-11-18 10:03:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/12f51fd1e2d4d2b51bcce554ef95ec10 |
|
| 2004-11-22 10:06:00 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9810f3cf9d4059cc014572242fa2e7e0 |
Suspension from Official Quotation
|
| 2004-11-23 09:47:00 |
Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e2cdd146e4121da09b9e3458622cf5dc |
|
| 2004-11-23 09:48:00 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b90fffa73cc6b66f86fb950a5d0810b |
Reinstatement to Official Quotation
|
| 2004-11-25 09:42:00 |
Chairman's AGM Address to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3dbd10ab3e692afacc9ee9761f1f6d48 |
Chairman's Address to Shareholders
|
| 2004-11-25 12:06:00 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ac37712707b17e9e5d47734868f41ff |
|
| 2004-11-25 14:49:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/38fe521fe00a9526057daa2c6dc0797c |
Becoming a substantial holder
|
| 2004-12-03 15:45:00 |
Appendix 3B & Section 708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6342f80b1c20406d0ea654e3e942a678 |
|
| 2004-12-07 12:31:00 |
Poultry Trials - Feed Conversion Improved by 11.7% |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3fdab9d22d787c23bde10389eb23de03 |
|
| 2004-12-07 16:55:00 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3468492acc42a59575fbb9ad0bb083c3 |
Notice of General Meeting
|
| 2004-12-22 15:48:00 |
Change of Director's Interest Notice x3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/683e7170850892409c0b0d69cc945e32 |
Change of Director's Interest Notice
|
| 2004-12-22 15:48:00 |
Appendix 3B - Conversion of Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28ef9763eaf8e2ec3a8fa9c961a2fc32 |
|
| 2005-01-11 15:12:00 |
Results of Meeting/Change of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b44096fb667c16af7152f612165a750a |
Company Secretary Appointment/Resignation
|
| 2005-01-13 16:55:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8acf5b9ba838b84ca050eefc65823879 |
Becoming a substantial holder
|
| 2005-01-17 13:30:00 |
Imugene Receptor Mimic Technology Patent Granted in US |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf03d5a2299c54d4dc0f1667ff3b8bab |
|
| 2005-01-21 11:17:00 |
Appendix 3B-Working Capital/Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34962b0f8b7bba0f421c77b1b14af591 |
|
| 2005-01-21 11:17:00 |
Finalisation of $5m Share Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/88f3d00a738977be2f645b44dbc02e99 |
|
| 2005-01-27 14:17:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1bbb15cd359fbaebeb781c0c09a68990 |
Commitments Test Entity - Second Quarter Report
|
| 2005-01-31 12:27:00 |
Appendix 3B - Issue of Performance Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc43111b0a909c61113772a1dd0b559a |
|
| 2005-02-07 17:46:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12ff48766d0ea7d6eb1712fbd801f962 |
Ceasing to be a substantial holder
|
| 2005-02-07 18:14:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b99828f507383800bd30bbb280713afd |
Change in substantial holding
|
| 2005-02-16 14:23:00 |
Securities Institute Briefing February 2005 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d554d4494919c6d02e461efa4c2a68df |
|
| 2005-02-16 15:11:00 |
Imugene Summary Briefing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/77b50d1073350b2bda38389a65c3e45e |
|
| 2005-02-21 15:59:00 |
Half Yearly Report/Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3fd1067a0b722d692bc67fcdf11f2dd2 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2005-02-23 18:33:00 |
Disclosure Document |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dffe7bb92a71cdc9bec5dce885a0508c |
|
| 2005-02-24 14:40:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4ef2d8a66ce4d25be2364397ed8d560 |
|
| 2005-02-24 19:03:00 |
Options Granted |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d81090f1a08b7395fa35f304cc708658 |
|
| 2005-04-29 11:00:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/79dd187398f872d5489fc1b77e93c1bf |
Commitments Test Entity - Third Quarter Report
|
| 2005-06-28 10:47:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d28561488f3ccc6f5896599922924579 |
Ceasing to be a substantial holder
|
| 2005-07-27 12:53:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f078456ce9a6e937edf74c8455f5439d |
Commitments Test Entity - Fourth Quarter Report
|
| 2005-08-26 10:35:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1482d6f7120eff85563d6a5ee486ea9a |
|
| 2005-09-08 14:40:00 |
Imugene completes OGTR dossier |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6502a19fb39b6e2e10393b770bc2eee0 |
|
| 2005-09-13 17:23:00 |
Preliminary Final Report & Full Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d866c2778bd1ec4731eff647d4332ad3 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2005-10-03 15:25:00 |
Response to ASX Share Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d3dde45b0420958ea4b64c583dfa4525 |
|
| 2005-10-12 10:34:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/692d7856c8ca384ff1c9b699760d53e6 |
|
| 2005-10-13 12:18:00 |
Licenses poultry productivity product to Merial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3490658cd18c73ae5a367c953a29a759 |
|
| 2005-10-25 18:16:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c12119432a9b13923b9b5a4432eca077 |
Notice of Annual General Meeting
|
| 2005-10-25 18:16:00 |
Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17ccda6f654a344989c1c6ba8b487068 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2005-10-31 10:58:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ec1565d0abaea60e44b3db5d3e0c976d |
Commitments Test Entity - First Quarter Report
|
| 2005-11-08 10:33:00 |
Investor Presentation November 2005 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f597bb9e4ee7c1f688b8fb99a4522b7 |
|
| 2005-11-24 12:59:00 |
Chairman's Address to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d77699bec7e716ca8ea5e48d2102c33d |
Chairman's Address to Shareholders
|
| 2005-11-24 15:49:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69cd358c0a44faaf3dae61340d3ea66f |
|
| 2005-12-06 11:22:00 |
Partners with Multinational to Construct New Poultry Vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/14e76dc2c357160bc53b269de3fb0cf1 |
|
| 2006-01-27 12:27:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/267eb3a2e5908b832790d212c3e4f16f |
|
| 2006-01-30 12:42:00 |
Granted licence for Poultry Growth Product |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8071671172738686b452cae47fa55d1c |
|
| 2006-01-31 18:10:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/efffad09153830e133739a2cbc43212e |
Commitments Test Entity - Second Quarter Report
|
| 2006-03-07 13:08:00 |
Opens New Research Laboratory Facility at La Trobe Uni. |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfbc9eae5572f17ef231f640bf030f6a |
|
| 2006-03-13 13:07:00 |
New Trial Commences for Lead Poultry Product |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b2138e31b2ba7b8ee1b0c385f63d5c65 |
|
| 2006-03-16 10:39:00 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0103c562b2a16e8b0e3e6bc230735e7b |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2006-04-28 15:16:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/920537e67fbe604ac4b8eec4a3357e99 |
Commitments Test Entity - Third Quarter Report
|
| 2006-05-31 11:06:00 |
Poultry Productivity Enhancer - Product Safety Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83bbb7458a204959cea1a23d408cb2b6 |
|
| 2006-06-30 17:36:00 |
Changes to Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5018650ed0c770b493365fb4b74d018f |
|
| 2006-07-04 09:07:00 |
Poultry Productivity Enhancer Passes Safety Tests |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7a15c793d278ba21fa8b1dab538ea1f1 |
|
| 2006-07-10 10:42:00 |
US Patent Interference to be Resolved Favourably |
1 |
https://app.sharelinktechnologies.com/announcement/asx/322ed9a2e19c24667850fd44f4111760 |
|
| 2006-07-17 12:11:00 |
Strengthens poultry patent protection |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7dcb8ddf24c496f78048d5fdd4ad1d49 |
|
| 2006-07-31 11:44:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a5af8c8d1256598a66e222ce8f6012d6 |
Commitments Test Entity - Fourth Quarter Report
|
| 2006-08-24 08:31:00 |
Two avian influenza vaccine candidates finalised |
1 |
https://app.sharelinktechnologies.com/announcement/asx/64ddf59d306f10c41d95335adf8ddbf3 |
|
| 2006-09-13 15:43:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8eb08bddd45348912f892909aa7e21d |
|
| 2006-09-18 16:19:00 |
Full Year Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a828a6a344bd52eabdecd7c9ef3be77 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2006-10-20 11:36:00 |
Poultry Productivity Enhancer Passes Further Safety Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/70db09e79a86d112b805de512a0b5c79 |
|
| 2006-10-26 12:19:00 |
Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a944ed2bb4ada0492e42eb80c99aa3f6 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2006-10-26 12:20:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0717077e6ec8abe1e8702cdf57584dc |
Notice of Annual General Meeting
|
| 2006-10-30 11:52:00 |
Avian influenza vaccine efficacy trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c6d5fe8acac19a466a185cd03c717b8 |
|
| 2006-10-31 14:21:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7ee13b646d4a7a463538b4364ea638b2 |
Commitments Test Entity - First Quarter Report
|
| 2006-11-08 11:45:00 |
Imugene offered $880000 grant for bird flu vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2df5986833dff559748d35bc04d918c1 |
|
| 2006-11-14 13:55:00 |
Poultry product progresses in Merial development program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b1d6ef2f38c8e34b58320c999d6d942e |
|
| 2006-11-15 09:35:00 |
Investor Presentation November 2006 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/498be703e49b5c2ef95d8d5a14cb023c |
Chairman's Address to Shareholders
|
| 2006-11-29 13:25:00 |
Chairman's Adress - 2006 AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/38bafa6db8f20f458d09630bef594e81 |
Chairman's Address to Shareholders
|
| 2006-11-29 15:25:00 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83d2466675d3ca37e44221cc85d42737 |
|
| 2006-12-14 16:07:00 |
Management Incentive Optons |
0 |
https://app.sharelinktechnologies.com/announcement/asx/075881d6f6cd5176ac5da538ec607ebe |
|
| 2006-12-14 16:11:00 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f4a1368ed63afceef55768c1ba2ec6a |
Notice of General Meeting
|
| 2006-12-15 10:51:00 |
Avian Influenza vaccine moves to final trial stages |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fd569bcc966eb685ffdcfd8afe809feb |
|
| 2007-01-08 09:43:00 |
Strengthens patent protection |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7fccd3583c44ce6f3c061aeb95fca6ae |
|
| 2007-01-10 08:30:00 |
Expiry of Options & Change of Director's Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65f13eb5c923365bbb05530eceb9683c |
Change of Director's Interest Notice
|
| 2007-01-17 11:50:00 |
Avian influenza vaccine trial update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fad47ab913cf812add2f7b4becbf8863 |
|
| 2007-01-18 19:17:00 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd0af89b8e1a956f6cde43f06717053e |
|
| 2007-01-18 19:20:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8bd596ae460ccbe6fd9a24f4fa1d2adf |
|
| 2007-01-25 12:16:00 |
Avian influenza vaccine trial update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3753af5d2558d12b7fdae08b01138ed |
|
| 2007-01-29 10:04:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/990be8578fb81dfef0d3da91980ecad1 |
|
| 2007-01-29 15:22:00 |
Avian Influenza vaccine success in US Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9e961667f28f224347cef5ed7e2fcc25 |
|
| 2007-01-31 15:37:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/456ab8633080775cb6397e0561533df3 |
Commitments Test Entity - Second Quarter Report
|
| 2007-02-01 17:14:00 |
Expiry of Listed Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d871ae68d18f8eadb54f85116301511 |
|
| 2007-02-27 18:34:00 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/04052c4ac4dcb1718b4e728a8c19a1cc |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2007-03-14 11:19:00 |
Avian Influenza Vaccine Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/03d2badc127a24eff4cf856eb5cfb3d9 |
|
| 2007-04-30 12:31:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/73c22f445a14a01760f36a3d6bc3a8ba |
Commitments Test Entity - Third Quarter Report
|
| 2007-05-21 09:36:00 |
Avian Influenza Poultry Vaccine Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/30edfc727a54c0b2dbfb539844f7705e |
|
| 2007-05-23 16:21:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c087c359ccb46d9aa2893706dc88cb6 |
Ceasing to be a substantial holder
|
| 2007-05-30 11:13:00 |
Strengthens patent protection |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9a4acd459d25b0ba86ff060ed0a722c1 |
|
| 2007-06-13 12:28:00 |
FINSIA Healthcare Forum Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63d5d07ea92df7787da510708bc850c6 |
|
| 2007-07-18 08:56:00 |
PRRS Vaccine Trial Commences in the US |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dccd89300b5fffca80379e9f7b866fcd |
|
| 2007-07-31 10:52:00 |
Fourth quarter activities and cashflow reports |
1 |
https://app.sharelinktechnologies.com/announcement/asx/64d7042745dd3172e12e2db0c2086882 |
Commitments Test Entity - Fourth Quarter Report
|
| 2007-08-30 17:55:00 |
Appendix 4E-Preliminary Final Report Year End 30 June 2007 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ee8f82ff3324e1a03a1445f6afdaeb46 |
|
| 2007-09-25 12:15:00 |
Expanded Vaccine Development Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00a39306acb32b0f5aec6b88e8ed0c12 |
|
| 2007-09-26 08:28:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7a012d6abaee8be3deae83cc5f32e74 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2007-10-12 08:25:00 |
Patent Protection Extended |
1 |
https://app.sharelinktechnologies.com/announcement/asx/39b9162a3c460ff12e2101399def899c |
|
| 2007-10-18 12:38:00 |
PRRS Vaccine Trial Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72c7802f08fbd4158b3088d727339c55 |
|
| 2007-10-25 13:02:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3515b0b42e6006f585b14ece7fe0eb3 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2007-10-25 13:03:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c892a029f79acdaba057cfd7531918eb |
Notice of Annual General Meeting
|
| 2007-10-31 13:26:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/967f103efe7cb7616f1e72f9b0d26310 |
Commitments Test Entity - First Quarter Report
|
| 2007-10-31 18:59:00 |
Expiry of Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/287e402ba69a790247a9417e29b1b246 |
|
| 2007-11-05 14:24:00 |
Patent Protection in China and Korea |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6600170e5cc35dd5f835d28fe1279f49 |
|
| 2007-11-27 10:05:00 |
2007 Chairman`s Address and Company Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f0cca6f770bcc19abffd4c90cb32c6f |
Chairman's Address - Other
|
| 2007-11-27 11:32:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4848439082d87436c5e404c51d8c56f7 |
|
| 2007-12-03 09:49:00 |
Non-renounceable Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6bce5a4a5b2090da051e9749faef81f |
|
| 2007-12-03 09:55:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c14dbf224d8d76a23680c9561ea96ce4 |
|
| 2007-12-11 12:08:00 |
Non-Renounceable Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f94f2c5b22c7fce8c1f216e1839ad76f |
|
| 2007-12-17 12:59:00 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/042ceae451a16942acbb8c2635480ad3 |
|
| 2008-01-18 17:33:00 |
Rights Issue - Notification of Shortfall |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31ed8efe25149ac09906b34f235c21c5 |
|
| 2008-01-23 08:34:00 |
Rights Issue s708A Notice and Appx 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6116dbee992c36a876e1b7fd7b536487 |
|
| 2008-01-31 11:06:00 |
Allotment of Rights Issue Shortfall and s708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/333aa6d6718493dbc7fd22188a0b648a |
|
| 2008-01-31 15:31:00 |
Quarterly Activities Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0fb6143faf2eeae443849ca197b6c451 |
Commitments Test Entity - Second Quarter Report
|
| 2008-01-31 17:04:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/563651e123b4db06e6c9458ab7cbebb0 |
|
| 2008-02-01 16:07:00 |
Change of Directors` Interests x3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99f91c98e2c4c70b0f5302a689c00ca3 |
Change of Director's Interest Notice
|
| 2008-02-04 15:58:00 |
Notice of Initial Substantial Holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ea696efc249c77f0efbbe26fa72b4be |
Becoming a substantial holder
|
| 2008-02-06 11:03:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cdd256cdda5ad00627b75f64991d98e |
Change of Director's Interest Notice
|
| 2008-02-06 11:04:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db1cb61332db00faa2058e9c27ed5c9b |
Change of Director's Interest Notice
|
| 2008-02-29 08:25:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4c0142bf593f0a758d5b4970cae966f5 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2008-04-07 14:18:00 |
Cocci Vaccine Trial in Progress |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bbf6ec7807cef996e0503e413678911e |
|
| 2008-04-30 16:55:00 |
Quarterly Activities Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8d120bade36477093e52b4d52906897a |
Commitments Test Entity - Third Quarter Report
|
| 2008-05-15 10:22:00 |
Cocci Vaccine Trial Success |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cfc3beabebd14fc3e5496b43c67cfa06 |
|
| 2008-05-29 17:37:00 |
Company Secretary Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5003e8746a454f23796a16d0bfc896c7 |
Company Secretary Appointment/Resignation
|
| 2008-06-12 18:43:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93141214661b61589651d5502937d833 |
Becoming a substantial holder
|
| 2008-07-01 08:24:00 |
Advisor Incentive Options - Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22eff9fe1d600f67211cee9768c75dbb |
|
| 2008-07-04 12:27:00 |
Imugene`s PRRS vaccine for pigs enters further trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e9a9b63889933213e8a1ae6445857916 |
|
| 2008-07-18 10:42:00 |
Details of Company Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c72a9f7dbd17504b213447fb8485527a |
Details of Registered office address
|
| 2008-07-31 17:53:00 |
Quarterly activity and cashflow reports |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0eae9f1935a99004a93b54b015a5e71f |
Commitments Test Entity - Fourth Quarter Report
|
| 2008-08-20 14:41:00 |
PRRS Vaccine Trial Success |
1 |
https://app.sharelinktechnologies.com/announcement/asx/07e11d14cb10916385a3b908391ddc2c |
|
| 2008-08-29 17:52:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/af4ca46b3b6d9f4dcf6164f3adcd0c72 |
|
| 2008-09-09 11:36:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8ebe5692ce49d4eab34bfe074a40e41 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2008-10-10 14:00:00 |
PRRS Final Trial Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/91b412b8c819271c9d2dd950b5b98401 |
|
| 2008-10-13 11:22:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/70861cb19a48448f635e78bd8d9bf631 |
Change in substantial holding
|
| 2008-10-22 14:58:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/022b71281a1a8790ab763bf3e5c7947e |
Notice of Annual General Meeting
|
| 2008-10-23 16:14:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b8ecda6474259dacaf6d2e3b8848499 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2008-10-31 11:29:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b48ca795689db343b2d0423639217fd0 |
Commitments Test Entity - First Quarter Report
|
| 2008-11-28 10:45:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eae28a429fd57596f0bbc3337461835e |
Chairman's Address to Shareholders
|
| 2008-11-28 12:37:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abe9cffdb2e4d42ce417c204cfe0c431 |
|
| 2008-12-24 09:28:00 |
Change in substantial holding from UXC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12af39b740926e9710a7bef61ebc13a3 |
Change in substantial holding
|
| 2008-12-24 12:54:00 |
CAP Correction: Incorrect ASX Code - should be IGG |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8eff13bc4d9679469e2d253f4085de03 |
|
| 2008-12-30 10:13:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eff1076c6dd89c9c4d68dc2a68fb9b4b |
|
| 2008-12-30 10:29:00 |
Trading Halt - Amended |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a7ee3f62c30609b054ed442101962b54 |
|
| 2008-12-31 09:35:00 |
Imugene and Merial establish a Strategic Alliance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e02fd995b38adf38653810b182629c37 |
|
| 2009-01-30 16:12:00 |
Quarterly Report and Apprndix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1b9c0377077b7b8560d35a4ad113f074 |
Commitments Test Entity - Second Quarter Report
|
| 2009-02-26 11:41:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/46bdeeecc16cfaab7bc8c287c4b7e57d |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2009-04-28 13:36:00 |
Swine Influenza Vaccines |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4f3c4c18118c9173bfbabf982f96d5ba |
|
| 2009-04-30 13:34:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1ced8dbe510c2ad8c228d7eaf6a49ae4 |
Commitments Test Entity - Third Quarter Report
|
| 2009-05-07 11:54:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/428ec20af58065692f4e4f3fe8e9ec67 |
Change of Director's Interest Notice
|
| 2009-07-27 15:32:00 |
Swine Influenza Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/596979af7d02ce1576b237f283edddd3 |
|
| 2009-07-31 13:54:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/13dfed9369a6c7e0cc91eeccac7e9f9d |
Commitments Test Entity - Fourth Quarter Report
|
| 2009-08-14 09:26:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50e7d0118c5c506091094848ec9c8521 |
Change of Director's Interest Notice
|
| 2009-08-19 13:44:00 |
Change of Director`s Interest Notices |
0 |
https://app.sharelinktechnologies.com/announcement/asx/790bf0feaff1b6641a3a21b9708c5398 |
Change of Director's Interest Notice
|
| 2009-08-19 14:05:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1064a8569fab2b84387aa1e6a7a9069b |
|
| 2009-08-28 08:23:00 |
Appendix 4E and 2009 Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/282d6b722b94da864ab8f0e01fa4d9d7 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2009-10-27 19:21:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35a0c266dcd843182d4b97be41d4688b |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2009-10-27 19:26:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/172b11c21024dda74526a24ec8e29c8d |
Notice of Annual General Meeting
|
| 2009-10-28 19:10:00 |
Quarterly Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cf3e49420509a39d82e863e05a1c8127 |
Commitments Test Entity - First Quarter Report
|
| 2009-11-24 15:23:00 |
Strategic Alliance Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc8b64bbabb27b62df10d2764ada6050 |
|
| 2009-11-27 12:23:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/478d1e5a42f24af4ee70c6edb5eee93a |
|
| 2009-11-27 13:49:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bce8cc7496b8bce3947912d0039af47f |
Chairman's Address to Shareholders
|
| 2010-01-05 14:01:00 |
Expiry of Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7046da8575d0db4e5e058c9c375e0f49 |
|
| 2010-01-05 14:01:00 |
Change of Director`s Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6eac6347ecc56ea876afa0f04a80cf08 |
Change of Director's Interest Notice
|
| 2010-01-11 09:00:00 |
Strategic Alliance Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c7f8284e81ebc30ba73f092904c696f5 |
Asset Acquisition & Disposal - Other
|
| 2010-01-29 19:03:00 |
Quarterly Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/519fbd86b587aba6803f4605b48916fc |
Commitments Test Entity - Second Quarter Report
|
| 2010-02-25 14:47:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b799862abcd4f697a3e86fea589b589b |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2010-04-07 11:15:00 |
Investor Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/491cab009fc29275d75f669f436bf434 |
|
| 2010-04-30 14:59:00 |
Quarterly Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f6a7aa2df10ef5a2ce396a9974cbe600 |
Commitments Test Entity - Third Quarter Report
|
| 2010-07-02 10:40:00 |
Shareholder Update Commercial Negotiations |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0cad9a0d0e991a3a737d614c75ea182a |
Asset Acquisition & Disposal - Other
|
| 2010-07-30 14:23:00 |
Quarterly Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/75b9f805ae90f2144d4435fee3ca811b |
Commitments Test Entity - Fourth Quarter Report
|
| 2010-08-31 18:05:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dfcb34ddfbbb5a4ca643b296aa945136 |
|
| 2010-09-16 09:00:00 |
Second Successful PRRS VaccineTrial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8758a4e6eb8bd32e2c3af6983afcf417 |
|
| 2010-09-30 18:01:00 |
Full Year Statutory Accounts and Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/524b677e745c5bd0b1402bfdd37addc8 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2010-10-13 09:40:00 |
Imugene Signs Global Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8a542c5d6ca280729ba2ae597ff12817 |
|
| 2010-10-26 18:08:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf9c348e7020190b4125e54162b4849d |
Notice of Annual General Meeting
|
| 2010-10-26 18:10:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1aa320eb2603e4500dbd1d6ad092c037 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2010-10-29 16:17:00 |
Quarterly Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a6eb20bf9b6c41d69e853b3cb5c3fef8 |
Commitments Test Entity - First Quarter Report
|
| 2010-11-12 09:11:00 |
Receipt of Initial Fees From Licensee |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d1e31060694fdfbad1ada9d175ac17c4 |
|
| 2010-11-26 10:36:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0605cf5ab49dd10c30cf8805922ae0d |
Chairman's Address to Shareholders
|
| 2010-11-26 12:51:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea3246de90269cfbc8e38b4d3ae31906 |
|
| 2010-12-24 15:17:00 |
Policy for Trading in Company Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f024b30ac90e30231d0fad8e41e2d40 |
|
| 2011-01-31 13:55:00 |
Quarterly Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5816418ac190f872c91bca3deb7fcb16 |
Commitments Test Entity - Second Quarter Report
|
| 2011-02-25 19:48:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2a529e7a0b1df1715c8ff9fe485fc6a1 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2011-02-28 11:37:00 |
Revised 4D |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e266e82ccf35db89109f59de32790b5 |
|
| 2011-04-29 13:23:00 |
Quarterly Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/411353281c90156bcc9187aa2beab1da |
Commitments Test Entity - Third Quarter Report
|
| 2011-07-29 08:12:00 |
Quarterly Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c4e5106e85e0f0dfe27e63da18a00c06 |
Commitments Test Entity - Fourth Quarter Report
|
| 2011-08-29 18:14:00 |
Appendix 4E and 2011 Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3afb58bab99ff6b44e0f9ffad10b5b26 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2011-09-01 09:55:00 |
Trading halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b295ac0a85b7261ae07b5b2dfca26bec |
|
| 2011-09-02 11:22:00 |
Global License Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b0041eb4c3903a86792c74ab39d6095 |
|
| 2011-10-26 19:55:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/261edc1057f45a98d811d244fb3ab99a |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2011-10-26 20:04:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0201ccf1113bc23255496f683b56353a |
Notice of Annual General Meeting
|
| 2011-10-31 17:38:00 |
Quarterly Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a28b72519b2e9ad4d764afaaa444c6b9 |
Commitments Test Entity - First Quarter Report
|
| 2011-11-29 14:34:00 |
Technology Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/66b9e7f8312e7291eb261e107f06f559 |
|
| 2011-11-30 15:04:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0df946cd20c538756b24685360e03b8 |
|
| 2012-01-11 13:14:00 |
Technology Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/843f5ef32836cd1a2e676c7bee03c10b |
|
| 2012-01-24 19:35:00 |
Quarterly Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9246adeb1ec9c1970b1cee9c865af3d |
Commitments Test Entity - Second Quarter Report
|
| 2012-02-29 14:01:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6385dc9356957977bcfe8ce53839c8a |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2012-04-30 18:28:00 |
Quarterly Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/061e6eeb00bca53a2256b8f7fe9763bd |
Commitments Test Entity - Third Quarter Report
|
| 2012-04-30 18:49:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fae98fa98950d1ebd09591a7df6b4bcf |
|
| 2012-05-01 19:21:00 |
Acquisition of Drug Delivery Platform and Share Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2cf46869428ab75811bec6d0f5c7fd35 |
Director Appointment/Resignation
|
| 2012-05-01 19:22:00 |
Agreement reached with Imugene for sale of Linguet IP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d32ad08be6b278ff465b8f54db05f66a |
Company Administration - Other
|
| 2012-05-10 12:04:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9191ce73ccdc38d386522e8b514e4d45 |
|
| 2012-06-15 18:22:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2b20f2a8ed2e308ea4f966910e1fb15 |
Notice of General Meeting
|
| 2012-07-17 13:06:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e181739b51d12dec927c31fdab8cc70b |
|
| 2012-07-17 17:56:00 |
Imugene Limited shareholders approve Linguet acquisition |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f9093c5b67601e3121723018383ff08 |
|
| 2012-07-31 14:08:00 |
Quarterly Shareholder Update & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c2d621d2dd189a89db9b6aff2b31d55f |
Commitments Test Entity - Fourth Quarter Report
|
| 2012-07-31 16:36:00 |
Acquisition Completed, Board Changes & Share Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/12a44a308394412901c9cdd599359b6e |
Director Appointment/Resignation
Company Secretary Appointment/Resignation
|
| 2012-07-31 16:37:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93e4f536d10255e338b33442da72cb22 |
|
| 2012-07-31 16:38:00 |
Appendix 3Z - Graham Dowland Final Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06f99b28dc6a5c846a5bd16b18c1f1b9 |
Final Director's Interest Notice
|
| 2012-07-31 16:45:00 |
Appendix 3X - Fabio Pannuti Initial Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98afedc081a85d868620486267b244d6 |
Initial Director's Interest Notice
|
| 2012-07-31 17:27:00 |
Becoming a substantial holder from CGP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/026df1da3daa03bdb74567b9f194c4c7 |
Becoming a substantial holder
|
| 2012-07-31 17:35:00 |
Linguet transaction with Imugene complete |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b90122f1bf1101affc7e33450ec1a7e8 |
|
| 2012-08-01 12:02:00 |
Board Appointment & New Direction |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5e982c1e4b25e77d7d40b1015ce693d |
Director Appointment/Resignation
|
| 2012-08-01 12:02:00 |
Appendix 3X - Steve Harris Initial Directors Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56fbaf1cb241b589aaf5d03318e9ef20 |
Initial Director's Interest Notice
|
| 2012-08-03 17:47:00 |
Details of Company Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1122cb2159304ac54ffb17065ecdfb1 |
Details of Company Address
|
| 2012-08-09 17:32:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44c6f4c31c9a3a5a4fcfb3d51d5edb1e |
|
| 2012-08-13 09:01:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bd0abf5aa9618b8fd2e08dc2c21351d |
Becoming a substantial holder
|
| 2012-08-13 17:13:00 |
Notice under section 708A of the Corporations Act |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3762b08106d41f3426e3dd3fce3f2ae0 |
|
| 2012-08-31 18:42:00 |
Appendix 4E and Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/06736a72c49c64c03f0f05f9ee0d2455 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2012-09-12 17:51:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6bc9c7f6021c88a511185d3cdedde47a |
|
| 2012-09-20 11:26:00 |
Imugene announces details of drug delivery program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/197f095bdd12c4ee21560364d68b593f |
|
| 2012-09-20 12:40:00 |
Imugene announces details of drug delivery program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4cdd6c8f6995903868874f6325e69e72 |
|
| 2012-10-02 09:04:00 |
Resignation of Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/724ced30a9b77966c910b2a155fe558b |
Director Appointment/Resignation
|
| 2012-10-03 17:45:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1960f13a4291b15c2435db6a19b2678f |
Final Director's Interest Notice
|
| 2012-10-29 09:00:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2964c9802ceb50304733c8235d37e135 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2012-10-29 09:03:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e14e3be6627d86601941e9fa668426e |
Notice of Annual General Meeting
|
| 2012-10-31 08:55:00 |
Changes to the Board of Directors |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a459e77b6f56d3026b85b7dfb314892a |
Director Appointment/Resignation
|
| 2012-10-31 17:27:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/500203c9ea5d73d9e01e1a465beea626 |
Commitments Test Entity - First Quarter Report
|
| 2012-10-31 17:29:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8bd3ae256fea3b8814c8a5eb24642105 |
Final Director's Interest Notice
|
| 2012-11-01 14:46:00 |
Consegna Elects to return Aspen Medisys |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7543d3b350276afb8de7d4b5b36d879c |
Asset Acquisition & Disposal - Other
|
| 2012-11-06 16:34:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/991e0e38ce27ed804f61ec0c5b7791d6 |
Initial Director's Interest Notice
|
| 2012-11-20 08:59:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0639f26d357c29babac6a3eededf7869 |
Chairman's Address - Other
|
| 2012-11-30 09:40:00 |
Chairman's Address & CTO Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d16e574ea170f80a0e0fb04d008e232d |
Chairman's Address to Shareholders
|
| 2012-11-30 11:59:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30dc328ef83df87f5585bb9333c4d775 |
|
| 2012-12-20 09:04:00 |
Appointment of joint Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53058e29b5663dad22d9734634dcca7c |
Company Secretary Appointment/Resignation
|
| 2013-01-31 18:35:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7b4d0972e999b1799b4e8398c3c6e31d |
Commitments Test Entity - Second Quarter Report
|
| 2013-02-11 09:35:00 |
Imugene Announces Board and Management Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb497880d06422bbdd77885aa999cb81 |
Director Appointment/Resignation
|
| 2013-02-11 10:16:00 |
Reply to Query - Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6bd418ae286b88f6d29749937d0346fb |
|
| 2013-02-13 10:13:00 |
Appendix 3X - Initial Director's Interest Notice (NE) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49c01c00ce496e5bce379af63a5e3b6c |
Initial Director's Interest Notice
|
| 2013-02-13 10:15:00 |
Appendix 3Z - Final Director's Interest Notice (FP) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/394a63eb268ce0a43a3477eb9355e4c1 |
Final Director's Interest Notice
|
| 2013-02-13 10:17:00 |
Appendix 3B & 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b134c62c3826b4fc13c9715ec8b7aa65 |
|
| 2013-02-28 15:23:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f0af6652560dd072a032f59f77a60fef |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2013-02-28 15:23:00 |
Half Year Financial Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8da85187be63e1806c7e58335e8af427 |
|
| 2013-03-05 08:32:00 |
Imugene to be awarded Japanese patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/921ef7a4b08600b11fcc2fe1a82cff09 |
|
| 2013-04-29 16:35:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c39dccfadc10215b3da3a772d991f62 |
Commitments Test Entity - Third Quarter Report
|
| 2013-04-30 08:18:00 |
Imugene granted Chinese patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9a665099043051d3521437eb02897d46 |
|
| 2013-04-30 08:56:00 |
Share Purchase Plan - Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9167a59960870824c9c4b2b64f434c51 |
|
| 2013-04-30 09:01:00 |
Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/657bb2760d53673f5920f7b1081bac31 |
|
| 2013-04-30 09:10:00 |
Share Purchase Plan - Offer Document |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4aae50a1a723f8d5721903108e5650ff |
|
| 2013-05-01 08:51:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/338a0ee908b2ba5a42bff74550d0592f |
|
| 2013-05-02 09:15:00 |
Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/80f4a2eca51076af87ed54a4acfd80ad |
|
| 2013-05-08 09:12:00 |
Research Report on Imugene Drug Delivery Technology |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d4e943cc82f5c3b9a82784512c59bb7 |
|
| 2013-05-23 09:02:00 |
Imugene progresses Vitamin D development program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8f4cb5c7ac46d97915145bdaad767b38 |
|
| 2013-06-04 09:07:00 |
Share Purchase Plan Results & $181K R&D Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/07c8584cce77b36634e80d44d24b9233 |
|
| 2013-06-04 09:56:00 |
Appendix 3B - Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d3c244e80bbb8711804253b48508eec |
|
| 2013-06-07 18:29:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/463ff4cd429d4ece62301bf67b4b4b0a |
Change of Director's Interest Notice
|
| 2013-07-02 08:54:00 |
Progress on Linguet Ibuprofen formulation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/016b25c5bfbaf984154538fbbf0a45b7 |
|
| 2013-07-11 18:32:00 |
Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e845977428aaa2589fe9899d3fa4d665 |
Alteration to issued capital
|
| 2013-07-29 13:11:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cdb0f93773d8c36195f9a9f3e3f27d8d |
Commitments Test Entity - Fourth Quarter Report
|
| 2013-08-01 19:25:00 |
Appendix 3B - Release of shares from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42bfd89a14d9b4e5ad40105a11bf9515 |
|
| 2013-08-07 09:16:00 |
Japanese patent for novel drug delivery technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/65c127f2ea8258a05cf1b67366bb3ccd |
|
| 2013-08-08 08:55:00 |
Vitamin D development program at commercialisation stage |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d8f76ae74a49f4d51f21eb307c6af6d6 |
|
| 2013-08-14 10:31:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7bb5eddcb71904974fc0632c4c0028d5 |
Ceasing to be a substantial holder
|
| 2013-08-29 13:10:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8892c22f26b87e0d918667eb10c48ff |
|
| 2013-09-04 17:35:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/274a77e8e20c700bf2019b85f9ae7a07 |
|
| 2013-09-18 09:42:00 |
Imugene discontinues ibuprofen development |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a3d7b72b3fbd899e53abcffc50c43eb5 |
|
| 2013-09-19 10:02:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba170e5a6c7c360d5cb7488c7f63e3ac |
Security holder details - Other
|
| 2013-09-20 14:23:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db8a124f4670c2694706617873941bb9 |
Becoming a substantial holder
|
| 2013-09-20 16:36:00 |
Change in substantial holding from CGP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b77c33096e827ef9614884b9517a5c8f |
Change in substantial holding
|
| 2013-09-25 16:03:00 |
Updated Securities Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c13dc5454ea33ed08583258c1f17efde |
|
| 2013-09-27 11:05:00 |
European patent for novel drug delivery technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/74325457fa4420158cc142693817d6a1 |
|
| 2013-09-27 15:20:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d057c9f25e1a10dceda5634d603e5a59 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2013-10-16 08:46:00 |
Ceasing to be a substantial holder - JP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1996e7d45dd87e450a89b73db62e5937 |
Ceasing to be a substantial holder
|
| 2013-10-21 08:33:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7afb0f555b4d613b103260b43f8fb130 |
Notice of Annual General Meeting
|
| 2013-10-21 09:32:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/73d39dcd215de9230a20225e6eb8773b |
|
| 2013-10-23 09:13:00 |
Imugene to acquire Biolife Science Qld Limited |
1 |
https://app.sharelinktechnologies.com/announcement/asx/479b7d61fdec99250b5551cf47610f41 |
|
| 2013-10-23 09:32:00 |
Presentation and Q&A - Acquisition of Biolife Science Qld |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13bed146dcbd59651bcd528a4d25b551 |
|
| 2013-10-23 09:41:00 |
Capital Raising Complete |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ac4d5597ae4f6cffdbf98eac4f6ecebe |
|
| 2013-10-24 16:22:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/afc6fc8c5f95736194722740208fcd4a |
Commitments Test Entity - First Quarter Report
|
| 2013-10-31 08:36:00 |
Appendix 3B & Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d54defdcb93d9a09763cad2cd175d4c4 |
|
| 2013-11-04 18:59:00 |
Private Placement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8579b5d0dadbb70846be399dab177f5 |
Company Administration - Other
|
| 2013-11-06 10:16:00 |
Appointment of Dr Axel Hoos as a Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61cef5bf73cae20724f70ad725490734 |
Director Appointment/Resignation
|
| 2013-11-18 18:44:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff90242abe56ee8adcd6bcd39e45a449 |
Notice of General Meeting
|
| 2013-11-20 09:54:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11a4c4a806e83d907568e7d88db91995 |
Chairman's Address to Shareholders
|
| 2013-11-20 13:00:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d350ed4948d10b0bbf083294eccf26f4 |
|
| 2013-12-09 16:41:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2028dbd85e232ff47cbdac1f463e1b7a |
|
| 2013-12-10 14:14:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfdc26908c596b33347ad0780b81eae2 |
|
| 2013-12-19 09:07:00 |
Imugene Secures Important Intellectual Property |
1 |
https://app.sharelinktechnologies.com/announcement/asx/44fefd889284fdb63a13c158dc788941 |
|
| 2013-12-20 11:20:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c319403c4e72f641f8558137a518c0c |
|
| 2013-12-20 13:05:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd0fdcac13242ac7bfb9dd0e8a03196c |
|
| 2013-12-20 13:10:00 |
Settlement of Biolife Science Qld Ltd Acquisition |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b81e521ff0109d1ca140bc5007ed1ec1 |
|
| 2013-12-20 14:23:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b19d2d8bcfd02a27465a191c9f3926c |
Becoming a substantial holder
|
| 2013-12-23 14:56:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0eaa188904c0773d96974ded47f4c18 |
Becoming a substantial holder
|
| 2013-12-23 15:02:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9a74921c6745a1daed55ddbdd08eac5 |
Becoming a substantial holder
|
| 2013-12-23 15:05:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ecb1117248e4f17155319d326aa95e8b |
Final Director's Interest Notice
|
| 2013-12-23 15:43:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/834d651f7b204528f3bc950491ad4dc8 |
Change of Director's Interest Notice
|
| 2013-12-23 16:06:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16baa1c7f893b01736027b74fed05308 |
Becoming a substantial holder
|
| 2013-12-24 10:04:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd5de006cfd8010ef84276759d86b281 |
Initial Director's Interest Notice
|
| 2013-12-24 11:27:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/58f8ed8b3a56e6ed64e3027cd08462d4 |
Becoming a substantial holder
|
| 2013-12-24 11:27:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e555e221b61c182d43b59ae39f789605 |
Change of Director's Interest Notice
|
| 2014-01-20 09:24:00 |
Scientific Advisory Board Appointments |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2099a353f16391dafc56f6c20048f3ac |
|
| 2014-01-29 14:34:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9765e6c93cf7ec865c78e5b1e609df08 |
Commitments Test Entity - Second Quarter Report
|
| 2014-02-25 11:03:00 |
Imugene Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d89699ad67fe20b704664caee5db2840 |
|
| 2014-02-27 15:48:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4407537fc60db9e302bed864dc050bee |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2014-03-17 09:03:00 |
IMU Commences FDA IND Process for Gastric Cancer vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/604e66fb843c547b86a1ba51873ae549 |
|
| 2014-03-24 09:08:00 |
Imugene Allowed Israel Patent for Cancer Vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/30d9f852d126a4fff3a5fa0fba066ef8 |
|
| 2014-04-17 16:28:00 |
Change of Director's Interest Notice (NE) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b0ee00b6918bb3417428874f35dab4e |
Change of Director's Interest Notice
|
| 2014-04-23 11:32:00 |
Gastric cancer specialist joins Imugene SAB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/977b1df860544c210bb8f96c8c3b30a4 |
Company Administration - Other
|
| 2014-04-23 14:56:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6c4bac982a6ad0f2bb98db8f232b70f9 |
Commitments Test Entity - Third Quarter Report
|
| 2014-05-05 15:52:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f02cb7ff9e9069db0cde058613eb94b |
Change in substantial holding
|
| 2014-05-27 12:12:00 |
Imugene Commences Manufacture of its Gastric Cancer Vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3fc0d08e6989d60e68c70e802a370dc5 |
|
| 2014-06-11 09:46:00 |
Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6fe260ab9e3063cc3f8728b6ca8fdb4b |
|
| 2014-07-07 08:28:00 |
Otto Buttula appointed Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7f88e9e6fe895ef33592ad19aee2a3f |
Director Appointment/Resignation
|
| 2014-07-08 09:23:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ec4df3bda3db928012f6d439ace3baa |
Initial Director's Interest Notice
|
| 2014-07-16 09:28:00 |
Mymetics Engaged to Manufacture HER-Vaxx |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3a4b51544a0447dd8d3e47e14e1806e9 |
|
| 2014-07-25 10:30:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6847e2490307ab64017536d6458ef3b2 |
Commitments Test Entity - Fourth Quarter Report
|
| 2014-07-29 09:34:00 |
HER-Vaxx patent application receives US Notice of Allowance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/12cb362b5bd0f38df53568c76ad7f02e |
|
| 2014-08-26 09:06:00 |
Charles Walker appointed Imugene CEO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b62524941860f81691e0e66b3750fdb4 |
Director Appointment/Resignation
|
| 2014-08-28 10:33:00 |
Investor Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3426b8acef447c7e633f0547c100655a |
|
| 2014-08-28 17:37:00 |
Appendix 4E and Annual Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/85c4d437480610649253200f6bce2c87 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2014-09-08 09:11:00 |
Research Agreement with Medical University of Vienna |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d30194e1881defda561179882dc7731f |
|
| 2014-09-15 09:02:00 |
Swiss Drug Manufacturer to Speed Her-Vaxx Development |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8eec83868fd15bcaa2d4de2a4d2d5b4b |
|
| 2014-09-16 13:37:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff717852df2cd54af57e6f97fdd8754d |
|
| 2014-10-08 09:42:00 |
Imugene HER-Vaxx patent granted in US |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6d3a2433025135f1f77ceb85cde1e3f2 |
|
| 2014-10-21 13:16:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b51672cd69efc4b369e288ed2129346e |
|
| 2014-10-23 09:28:00 |
Resignation of Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46c51733af90e5856ace85f8f55f2f81 |
Final Director's Interest Notice
Director Appointment/Resignation
|
| 2014-10-24 14:53:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed8ec6bc033cc0a6eb620e067f280c98 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2014-10-24 15:42:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e51dfea99a07d54e61af17cf2a1f4af4 |
Notice of Annual General Meeting
|
| 2014-10-31 17:21:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4a49db08e4d9f215b7c0134c27c20f93 |
Commitments Test Entity - First Quarter Report
|
| 2014-11-03 09:16:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8403352edc7dd8446182cf8ee9614e10 |
|
| 2014-11-05 09:08:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e25a786138f544b71df1249e97883802 |
|
| 2014-11-05 09:12:00 |
Share Purchase Plan Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c7caeacda66554c289bbb2169bbf4ab |
|
| 2014-11-05 09:24:00 |
Capital raising for clinical development of HER-Vaxx |
1 |
https://app.sharelinktechnologies.com/announcement/asx/730cd9fa0cd474d08a401ba949fa6569 |
|
| 2014-11-05 19:26:00 |
Correction to Record Date of Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/10b236bdc8844a4399fa53fc042ce339 |
|
| 2014-11-07 16:34:00 |
Share Purchase Plan Offer Document & Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d0588b6f81ed658357576aaaa5a448a3 |
|
| 2014-11-12 17:08:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81ede9ee74724954dd537fecce43194d |
|
| 2014-11-12 19:52:00 |
Additional placement details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a71088758c51920cabe6a2e860262fe2 |
|
| 2014-11-13 13:32:00 |
Placement Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed5b547d402a83af0e2fef2b389d13dd |
|
| 2014-11-25 10:50:00 |
AGM 2014 Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a769b143f94b43d5330389b251f9a555 |
Chairman's Address to Shareholders
|
| 2014-11-25 11:01:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ab4e878f649036eaed7b49ba7d0281af |
|
| 2014-11-27 09:08:00 |
Extension of Share Purchase Plan Closing Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03512d2c9cff6f77ed38212fccef17aa |
|
| 2014-11-28 09:44:00 |
Imugene to divest Linguet drug delivery technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d32527a2d74231f5a8e5d54ad4884c4c |
|
| 2014-11-28 10:28:00 |
Publication of Research Note |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46c77fa4c61f6128fd1730726b4a25a2 |
|
| 2014-12-01 10:06:00 |
HER-Vaxx peptides demonstrate high level of activity |
1 |
https://app.sharelinktechnologies.com/announcement/asx/152ab5bb14e0a32ba2a11934916c77af |
|
| 2014-12-04 09:42:00 |
New Research Note available from Edison Investment Research |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0fd4ad182ca7bb9a0bdafc34d165f872 |
Company Administration - Other
|
| 2014-12-05 19:05:00 |
Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb4ab8cf3c109f343b4423c02d84d3e1 |
|
| 2014-12-09 09:57:00 |
Further placement & close of SPP raising over $3.5m in total |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5743472e292708ea5273e26d8b1d6e26 |
|
| 2014-12-15 11:40:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b7080e43e5c6cc9142a9f9eab0457f93 |
|
| 2014-12-16 08:38:00 |
Completion of share purchase plan allotment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2e811f96071263cb5478d8a42788fa1 |
|
| 2014-12-16 10:04:00 |
Change of Director's Interest Notice (OB) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93cbe51a92d03735091306b90ffd553a |
Change of Director's Interest Notice
|
| 2014-12-16 10:10:00 |
Change of Director's Interest Notice (PH) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d422ec0cbcefde7500ace03987b0545b |
Change of Director's Interest Notice
|
| 2014-12-16 16:33:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3b7961ea1762c65b9e35a133ceb031f |
Ceasing to be a substantial holder
|
| 2014-12-16 16:34:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6aed520119eb123c86a6c74df1ad2ceb |
Change in substantial holding
|
| 2014-12-16 16:36:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/310eeb800fb6c5c10a3bd291899ffad4 |
Ceasing to be a substantial holder
|
| 2014-12-16 16:38:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b04d4ff27866baf430cf2e12ee079cb1 |
Ceasing to be a substantial holder
|
| 2014-12-18 19:27:00 |
Notice under section 708A of the Corporations Act |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b5a396f126d8b2803af7f45ae9aede5 |
|
| 2014-12-30 10:02:00 |
New milestones in preparation for HER-Vaxx clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b8a60d1fb87f7b718c102618a845deab |
|
| 2015-01-06 19:18:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e1ee69a04e3935aa7f78f59346fcfc5 |
|
| 2015-01-13 11:28:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01d2e475e353f5f5a7a38f1b7cadce74 |
|
| 2015-01-28 19:25:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38daa6a3f365766092dddf3fabc4723b |
Commitments Test Entity - Second Quarter Report
|
| 2015-02-02 10:00:00 |
Appointment of Charles Walker as Managing Director |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c548571a20dc29a043e0226895edddde |
Director Appointment/Resignation
|
| 2015-02-02 18:17:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34fb576679d686227b99e145bd6d4798 |
Initial Director's Interest Notice
|
| 2015-02-10 13:48:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ac05893b8e29d92023cfbfee00dd70a |
|
| 2015-02-18 09:35:00 |
Imugene Receives $230K Research and Development Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b6c9f9cdaac53930dc387ead7203820a |
|
| 2015-02-20 17:18:00 |
Response to Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2ca403d9fb8897e01622f9625aec1e0e |
|
| 2015-02-27 10:00:00 |
Summary of Half Year results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb05f213dae52cd67a02130908ab1e9e |
|
| 2015-02-27 10:08:00 |
Appendix 4D - Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/41b785804bbfff198a4855935f86bd83 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2015-02-27 16:32:00 |
Grant of Options to Dr Nick Ede & Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc38a01e4fcdd6e381943aae5f99f75a |
Security holder details - Other
|
| 2015-03-06 10:02:00 |
Imugene to Present at 27th Annual Roth Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe7f59cc6ec7b5180c2c146468dcca62 |
Company Administration - Other
|
| 2015-03-10 09:31:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9a71ca33feee9dae860c38e7e7ce9bc5 |
|
| 2015-03-24 09:59:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/000223f2c4a481bfe93ecc6c0b585eb7 |
|
| 2015-04-14 10:01:00 |
New Research Note available from Edison Investment Research |
0 |
https://app.sharelinktechnologies.com/announcement/asx/89c910d0ac41c855e136329d6c275884 |
|
| 2015-04-20 08:52:00 |
HER-Vaxx Re-Formulation Increases Efficacy Ten-Fold |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3f1761c22873f2676b3aa4c3b969b56 |
|
| 2015-04-20 09:13:00 |
News Update and Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ef0ab040e917368d7ddc7c2e3f16b82 |
|
| 2015-04-21 09:28:00 |
Imugene Files New HER-Vaxx Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/79651641b4ca46452ae41888d2c695ab |
|
| 2015-04-29 15:35:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa45a65641ccebd75b7e49b9de51d604 |
Commitments Test Entity - Third Quarter Report
|
| 2015-05-22 09:07:00 |
HER-Vaxx superior to Herceptin in tumour model |
1 |
https://app.sharelinktechnologies.com/announcement/asx/073790dea339853337f1edefd0e28908 |
|
| 2015-06-05 09:02:00 |
Prof Ursula Wiedermann Appointed Chief Scientific Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0c33dda435953b07d141b2bfa37715a |
Company Administration - Other
|
| 2015-06-12 11:32:00 |
Change of Share Registry Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f2e169cb3f4be88d9fca97e4cf06d45 |
Details of Share Registry address
|
| 2015-06-29 08:33:00 |
Proposed Issue of Options to Dr Axel Hoos |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef821b01d8d0b796636540280374c40c |
|
| 2015-07-01 08:31:00 |
CRO Appointed to Conduct Phase 1b/2 Gastric Cancer Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c957c521ffc911f4c362a77a8053ed48 |
|
| 2015-07-13 10:56:00 |
New Research Note available from Edison Investment Research |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72eaa4cdd94e7796333d6fbb93279bb3 |
Company Administration - Other
|
| 2015-07-24 17:04:00 |
Change of Share Registry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f45cac7981bcb0aa54a922feb45cbd0 |
Details of Share Registry address
|
| 2015-07-30 18:53:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7357bb51ba01301dbe685092055d8ca4 |
Commitments Test Entity - Fourth Quarter Report
|
| 2015-08-27 09:16:00 |
Immuno-oncology Specialist Appointed Chief Operating Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/38bd1beb8c13a296f61d23edf0004aad |
Company Administration - Other
|
| 2015-08-31 17:18:00 |
Appendix 4E and Annual Report 2015 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/80e65f98b9c3ce46fac18bdf2ec8d027 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2015-08-31 17:22:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac498e87f9f5ae667648e1a863f0d1f3 |
|
| 2015-08-31 17:26:00 |
Summary of Full Year Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a76720378ec61dba935be674aff1c0d7 |
|
| 2015-09-07 09:02:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e47f7775ac51ee60fc05d68a86852f4e |
|
| 2015-09-08 09:59:00 |
Imugene Announces Successful Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/360722812ec5fce89c0bf45df6613f54 |
|
| 2015-09-08 15:13:00 |
Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3283367246ed7bd48a3621e770025e44 |
|
| 2015-09-14 16:34:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f4e0f7da82bed6984c843c005ef943c |
Notice of Annual General Meeting
|
| 2015-10-13 14:02:00 |
Imugene announces bonus options issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b662a11b652eea5c4adb2f3727ea034b |
Bonus Issue/In-Specie Issue
|
| 2015-10-15 10:35:00 |
AGM Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd3d3715773c6a5b0c752c469f353987 |
|
| 2015-10-15 11:46:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/312fa5fee6a4a777b04e88abda367326 |
|
| 2015-10-23 17:06:00 |
Appendix 3B - Loyalty Option Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95ac6319ae6e6c5c49e0178802b3ec44 |
|
| 2015-10-23 17:12:00 |
Prospectus for Placement & Loyalty Options |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a2f0d0eaa5bbb65cdafa5ecf7e01b2be |
|
| 2015-10-23 18:03:00 |
Letter to Option Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53a2c138d9133fcf4b4893ff0b58a944 |
|
| 2015-10-26 11:24:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6beae0f9543e3741e1a2b685810ff4cd |
|
| 2015-10-28 11:01:00 |
Imugene Receives $755k R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e16c11b0c14b96ed56b5d9907adb020b |
|
| 2015-10-28 15:30:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c33800927dad3516ff52a4d85fcb7a63 |
Commitments Test Entity - First Quarter Report
|
| 2015-10-28 17:48:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ea463fc4e8af0255648b55e7798b287 |
Ceasing to be a substantial holder
|
| 2015-10-30 09:26:00 |
Change of Director's Interest Notice (CW) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/800413b7b6ea9954e04e53e69364f9e5 |
Change of Director's Interest Notice
|
| 2015-10-30 09:27:00 |
Change of Director's Interest Notice (OB) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d29f186d28542d5d9a9d7f1f9781291c |
Change of Director's Interest Notice
|
| 2015-11-02 15:24:00 |
Change of Director's Interest Notice (AH) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f43c8a2efa61a124004a152440b0b9b |
Change of Director's Interest Notice
|
| 2015-11-09 13:58:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44a61a6cf3704b60358bddcae91a080a |
|
| 2015-11-13 15:08:00 |
Change of Director's Interest Notice (CW) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/833f991cdee67933bd173c7b73b03fad |
Change of Director's Interest Notice
|
| 2015-11-13 15:10:00 |
Change of Director's Interest Notice (OB) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8200829f4cb32493340a704333c8f804 |
Change of Director's Interest Notice
|
| 2015-11-13 15:11:00 |
Change of Director's Interest Notice (PH) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/14f862197902b9b0af4610a1017d63d1 |
Change of Director's Interest Notice
|
| 2015-11-23 17:02:00 |
Change of Director's Interest Notice (OB) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/156fc2412316b71966bdf77863bf0baf |
Change of Director's Interest Notice
|
| 2015-11-30 17:34:00 |
Change of Director's Interest Notice (OB) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/217603dfc6ef0713932abbefa18083bb |
Change of Director's Interest Notice
|
| 2015-12-08 13:35:00 |
Change of Director's Interest Notice (PH) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1dc68d877de7d3ed4c93ad9386cf173 |
Change of Director's Interest Notice
|
| 2015-12-11 17:44:00 |
Change of Director's Interest Notice (OB) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42150f3e519a59c393eb6494e6ab1a24 |
Change of Director's Interest Notice
|
| 2015-12-14 08:42:00 |
Novotech appointed Contract Research Organisation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e77cc2b6ed4b8f5c089dd5cc18841118 |
|
| 2015-12-14 18:28:00 |
Change of Director's Interest Notice (PH) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8d9acc9619ea97ae8152cf93bfd21ce |
Change of Director's Interest Notice
|
| 2015-12-17 09:26:00 |
Director Resignation - Mr. Otto Buttula |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29e427234f513d34d1b324c7d69aa840 |
Director Appointment/Resignation
|
| 2015-12-18 09:04:00 |
Imugene key HER-Vaxx patent granted in Europe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1cc71680b8fce2cb53aa4790cc4c6b3c |
|
| 2015-12-22 11:50:00 |
Imugene to present at the 2016 Biotech Showcase |
0 |
https://app.sharelinktechnologies.com/announcement/asx/277eebe772744e3e87e3254b0b2f695f |
|
| 2016-01-04 15:43:00 |
Stuart Roberts named as Head of Corporate Development |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7478385ee6cf9fb3e639a817b8bc9d1 |
Company Administration - Other
|
| 2016-01-05 09:16:00 |
Dr. Anton Uvarov appointed Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f4b7ff8575360763fd95303a4514fc78 |
Director Appointment/Resignation
|
| 2016-01-07 15:37:00 |
Initial Director's Interest Notice AU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/444314efcd5ccd3779953f3e602bd5c1 |
Initial Director's Interest Notice
|
| 2016-01-11 16:53:00 |
Biotech Showcase Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d86cc28813db8289627dc33a8d0d2ab |
|
| 2016-01-15 15:21:00 |
Noble Financial Capital Markets Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ddc01e6cec27995b9692c713a4379b5 |
|
| 2016-01-18 09:46:00 |
Final Director's Interest Notice (OB) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b7e3dc1af55bbc5df6a1c7fa6e27090d |
Final Director's Interest Notice
|
| 2016-01-20 10:07:00 |
Partnership to Develop Mimotope Immuno-Oncology Platform |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4e50f7a6c01bd6122c2b86509d59f786 |
|
| 2016-01-27 15:58:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6343b2a9cb884ccb40bf68f4fe9f10fb |
Commitments Test Entity - Second Quarter Report
|
| 2016-02-10 09:27:00 |
Imugene to present at the RedChip Global Online Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca0b22d3f403ecabdf57cf0c909e00a7 |
|
| 2016-02-29 14:51:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/40df6fa3877636385e603ae353f84425 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2016-02-29 14:58:00 |
Imugene Results for December Half Year |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ef36e571855e6c0d7b49c145b05a3a2 |
|
| 2016-03-07 17:27:00 |
Manufacturing Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8e4b0203175aeadb6d40a5274b43bc3e |
|
| 2016-04-12 09:42:00 |
Dr Yelena Janjigian appointed as SAB member |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bae4984cc56791d9fe50e1bae5e4559 |
Company Administration - Other
|
| 2016-04-13 10:31:00 |
Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa0625be63edb6cbf1b9876d1353d919 |
Letter to Shareholders - Other
|
| 2016-04-21 10:24:00 |
Regulatory package submission for Her-Vaxx in Hong Kong |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e6849da8f79e31c2c4b1c5dffe255d42 |
|
| 2016-04-29 13:05:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f218177d498f5c903ae811e25fcfadb4 |
Commitments Test Entity - Third Quarter Report
|
| 2016-05-27 17:06:00 |
Corporate Development Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3d51f434a5f02339554839be1cfa7b5 |
Company Administration - Other
|
| 2016-05-30 09:14:00 |
Completes submission to Hospital Ethics Committees |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48595e4c5d89a63d49a3a541d2fd786a |
|
| 2016-06-15 08:21:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/acf6bd73f9cbec52b5cbacdd245cec12 |
Ceasing to be a substantial holder
|
| 2016-07-06 08:27:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6fc26607b3634f9aaba76a68ac59949 |
Becoming a substantial holder
|
| 2016-07-11 08:27:00 |
Imugene Receives Institutional Review Board Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/06a12a1c7b25d64db2003f7eddbf4b15 |
|
| 2016-07-29 12:14:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f4567a01cf0405607a5a26e7f4b4bbb3 |
Commitments Test Entity - Fourth Quarter Report
|
| 2016-08-11 08:30:00 |
Imugene Receives Institutional Review Board approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/093cc727369e73d907a2f5d6500e210b |
|
| 2016-08-22 08:20:00 |
Imugene Receives Approval to Start Gastric Cancer Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c2d1480d0dcf388057e051b2b8efb4fe |
|
| 2016-08-30 08:32:00 |
Imugene Final Cancer Vaccine Doses Delivered to GMP Depot |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e55803b119c7b41ba75ae3dd2695d0ed |
|
| 2016-08-30 08:56:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6178629b4026e242b15829645c95b180 |
|
| 2016-09-20 08:28:00 |
Imugene successfully completes preclinical animal studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c22bfd14ad7b285b251b8ff97d897ab7 |
|
| 2016-09-22 10:00:00 |
Imugene receives $1.3m R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0fdbb59beb213f026211e345f61df6bc |
|
| 2016-09-28 17:04:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9fa6afbbccd7a43c2115fd5926155905 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2016-09-28 17:12:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c04c16928f34acd956dab031b08a2eee |
|
| 2016-09-30 12:27:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18f59265a4fb2865df5ca0f5b6e48668 |
Notice of Annual General Meeting
|
| 2016-10-19 09:02:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b470e2812ebdaff5f23400df56d6456c |
|
| 2016-10-21 09:27:00 |
Imugene Share Placement raises $3.2 million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/40e7508a132edb1cc149e92f30d0a605 |
|
| 2016-10-27 13:20:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f9385ef7a64c5cadbdb514a505b55fb |
|
| 2016-10-27 18:55:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cdc02051e85211f616015ffb3a2a23bc |
Commitments Test Entity - First Quarter Report
|
| 2016-10-31 14:19:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b14f478d9c7478eee737b364e436e37d |
Becoming a substantial holder
|
| 2016-10-31 17:03:00 |
Director Resignation - Final Director Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cee3fffd88b72f937fb4ffd68dc915c |
Final Director's Interest Notice
Director Appointment/Resignation
|
| 2016-11-02 11:09:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eaece66fd6c637079da2df3b539eca27 |
|
| 2016-11-02 11:45:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b9216e10bd15e669610cce39c744fe2 |
|
| 2016-11-03 12:17:00 |
Appendix 3B, 708A Notice & Listing Rule 3.10.5A information |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8c72340f32d09f16a21b467912ea9f7 |
|
| 2016-11-04 16:15:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b40a123df20e99563bb74df2031341a5 |
Ceasing to be a substantial holder
|
| 2016-11-07 08:43:00 |
Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f6f22e94f00bccb7da0c79d2e8448ccc |
|
| 2016-11-07 15:55:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba04888ce52c74cf4f40afae0634dd14 |
Change in substantial holding
|
| 2016-11-09 08:52:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e90a2b7b5da0d10f7266af0df6144c03 |
Change of Director's Interest Notice
|
| 2016-11-21 15:38:00 |
Leslie Chong Appointed Chief Executive Officer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b1f3042f6a4f911af7b0ff8b94db4f79 |
Director Appointment/Resignation
|
| 2016-11-25 08:47:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d5748c1cf699e75f51de040bc5c0b60b |
|
| 2016-12-02 14:11:00 |
Imugene Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54e260c23324acc530a1efcc729ed67a |
|
| 2016-12-13 08:37:00 |
Acquisition of immuno-oncology technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/217ead2fd6cfe27ac9a8e4d5f5939173 |
|
| 2016-12-13 09:59:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1d210d4c1685eab9a66133271b0402ae |
|
| 2016-12-16 09:55:00 |
Response to ASX Aware Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0bc119e3bd6739174ea79a8ac7fcaea9 |
|
| 2016-12-19 08:29:00 |
Imugene progresses mimotope platform |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d7d0338104161ea121d8f20c39703843 |
|
| 2016-12-20 14:28:00 |
Investor Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71b27b14fafee7ccf9d2b34cd9d9ef0d |
|
| 2017-01-09 13:20:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54283e03d2b524fc20da79cfb013e06f |
|
| 2017-01-27 13:25:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e1713ae858d3463c1284c7c402453be8 |
Commitments Test Entity - Second Quarter Report
|
| 2017-01-31 13:59:00 |
Appendix 3B - Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84b68605d752d4b670a495bdc7954dfc |
|
| 2017-02-08 10:03:00 |
Letter to Option Holders - IMUO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eba259eb4a4c937968eace617668e2cd |
Letter to Shareholders - Other
|
| 2017-02-13 08:35:00 |
BMC Cancer journal publishes encouraging HER-Vaxx research |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6516888e841d608effc189c9d4369f32 |
|
| 2017-02-24 10:50:00 |
Appendix 3B - Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4cdf2bf9a8fd9ef138d2b178edc4ed4 |
|
| 2017-02-27 08:29:00 |
Intellectual Property Strengthened Around Lead Clinical Drug |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f8976bdb050a261610d5b81a294a1a0f |
|
| 2017-02-28 16:13:00 |
Half Year Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/beb2aab2efe557d6e40924899442f258 |
Half Year Directors' Statement
Full Year Directors' Report
|
| 2017-02-28 16:13:00 |
Half Year Results Summary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9433796b440e64922f7e74eedb80572 |
|
| 2017-03-08 09:32:00 |
Letter to Option Holders IMUO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1609c639e62cd4249728c8ee606be391 |
|
| 2017-03-08 10:10:00 |
Update on Imugene Option |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b66f67d5641f56535650b047de0156c |
|
| 2017-03-10 11:56:00 |
Appendix 3B - Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5d437d4af05864fdee043d12b395ed3 |
|
| 2017-03-14 09:15:00 |
Imugene March Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e3907ee0d15f58a539acc8c01070ae7 |
|
| 2017-03-27 09:57:00 |
Appendix 3B (Exercise of Options) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f40f131d6c3fc0f14cde83da3c1adc96 |
|
| 2017-03-30 09:03:00 |
$1.35 million Options Underwritten |
1 |
https://app.sharelinktechnologies.com/announcement/asx/830c80c5079fb9dd8235c863e3a679de |
|
| 2017-04-06 09:57:00 |
Appendix 3B (Exercise of Options) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3430df865bc033af4a80a75c9f59245 |
|
| 2017-04-06 10:02:00 |
IMU Raises $3.0m from Options Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/937cba1530975bd916bf912e9c9959d8 |
|
| 2017-04-19 16:22:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/687e7badb39baf952284052f6482a7be |
|
| 2017-04-28 10:24:00 |
Appendix 4C - quarterly and Commentry Q3 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/019db465a5470fad2d71eee2e010d202 |
Commitments Test Entity - Third Quarter Report
|
| 2017-06-26 09:52:00 |
Change of address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc38c72ac75f92af63321f9aac261ca0 |
Details of Registered office address
|
| 2017-07-17 08:23:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/62ba8315e5b8375e1491106760ab69e4 |
|
| 2017-07-21 12:34:00 |
Imugene granted Canadian patent for Her-Vaxx cancer vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/42f1ac2b7e3b7ba5da19961085e07e98 |
|
| 2017-07-31 15:30:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d7b7b4968fb1fa2ada350f6d0670b209 |
Commitments Test Entity - Fourth Quarter Report
|
| 2017-08-25 17:38:00 |
Appendix 3B (Exercise of Options) and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/897948c5e2403e600c606a6a27f018be |
|
| 2017-08-31 08:29:00 |
Appendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fbdb1b480d4e12e9c78e4e4ecbbe7ab0 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2017-08-31 08:30:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee9b2d3f3c036306e092fca10c27c9bc |
|
| 2017-08-31 08:32:00 |
First Patient Dosing Commences of HER-Vaxx |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8fc0122a6e3e24cbfae65e7e364f7ffb |
|
| 2017-09-21 18:50:00 |
Appendix 3B - ESOP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6bb91a7d8fc1b0d57c6d32b93b1986d |
|
| 2017-10-06 15:48:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc289012a589dd456b9f94daa759ec4f |
|
| 2017-10-11 09:22:00 |
IMU Receives $1.1m R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3d66332d657349c25d852b05ec3cbdb |
Company Administration - Other
|
| 2017-10-12 09:37:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f5f9986b95eb4b2a7545dab55d62fdc |
Notice of Annual General Meeting
|
| 2017-10-13 10:36:00 |
Notice of Annual General Meeting & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2fec0bc33a030a727505f910270455b2 |
Notice of Annual General Meeting
|
| 2017-10-16 08:42:00 |
Expert Briefing - Latest Clinical and Commercial Advances |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e35f5e4d6fc0ffe223f831d0c07a85e |
|
| 2017-10-17 09:28:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/225a4504b56b6f3bc7db4439cdb891d2 |
|
| 2017-10-24 09:10:00 |
AusBioInvest Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f9924ddca62e535195ee4fff77244602 |
|
| 2017-10-26 12:52:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3fdf11df12a1cded679eae21fdea453a |
Change in substantial holding
|
| 2017-10-27 09:53:00 |
Appendix 4C - Quarterly and Business Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/434d0c9d8affaba35858bdbf0ac9fa6f |
Commitments Test Entity - First Quarter Report
|
| 2017-11-14 09:50:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fc3070b81892d14bfee5751877ad535 |
Chairman's Address - Other
|
| 2017-11-14 10:24:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54f0cd03da0d816238c1f8c362960e75 |
|
| 2017-11-14 13:56:00 |
Expert Briefing Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18f8c1e6ca7bd8dd4efc2f53301633da |
|
| 2017-11-21 09:21:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/294b60cbb2b8a98a8489801333ef022c |
|
| 2017-11-23 09:57:00 |
IMUGENE RAISES $8.7 MILLION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e23d770bcad14452343f2a8cdb674b2e |
|
| 2017-11-23 09:57:00 |
Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/88fd2b35a80a96fa9bdd6c2c18d10272 |
|
| 2017-11-23 09:58:00 |
CAPITAL RAISING PRESENTATION |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd72ad7e3024f677cc71559ef8e62721 |
|
| 2017-11-23 09:58:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5df93e7559378e36cb8bbf26ffbcfe6b |
|
| 2017-11-23 10:33:00 |
Imugene Entitlement Offer notice to eligible shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b98e1b3d83f2a1cb6423ece936cec58 |
|
| 2017-11-23 10:35:00 |
Imugene Entitlement Offer notice to ineligible shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1b1886adec7492dd022be21570cbfeb |
|
| 2017-11-23 10:39:00 |
Imugene Entitlement Offer notice to option holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d17e8c199b88faca9364f79b8b468951 |
|
| 2017-12-04 09:55:00 |
International Cancer Specialist Joins Imugene SAB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe5e5dda60eeaa9cd828af81ba79a9a1 |
Company Administration - Other
|
| 2017-12-05 09:47:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf273daaef0ef229fd073a1a59744466 |
|
| 2017-12-06 10:51:00 |
Appendix 3B and Required LR 3.10.5A Information |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1ece2ecef5923564a4379eb37b60eb5 |
|
| 2017-12-11 18:30:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31bbefda441f63614d8b74a2ffe535a2 |
Change of Director's Interest Notice
|
| 2017-12-11 18:33:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abd8a7aedd36d396f4c88eb99d5e23c1 |
|
| 2017-12-12 09:57:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b7c50434d511241613a2284619d2e1e |
Change of Director's Interest Notice
|
| 2017-12-13 11:25:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9db311845483ce9eb07e373ebd23cfdf |
Change of Director's Interest Notice
|
| 2017-12-19 15:53:00 |
Rights Issue Results & Shortfall Notification |
1 |
https://app.sharelinktechnologies.com/announcement/asx/69b06a24a39c2b8eb670a0a1128d84ac |
|
| 2017-12-22 11:22:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a3c637a92c238fd9faaa21f84f5abb2 |
|
| 2017-12-28 10:20:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6e6338bd670f40ceda4037eee442042c |
Change of Director's Interest Notice
|
| 2018-01-09 08:54:00 |
SF Biotech Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e13d529d3e136c1de398767692dc231e |
|
| 2018-01-29 10:01:00 |
Business Update - December Quarter Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c58564e5cca61083934e4ebb36792cab |
Commitments Test Entity - Second Quarter Report
|
| 2018-02-06 13:50:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/226ffacb3de775540ac4d83a9dada170 |
Change in substantial holding
|
| 2018-02-06 16:24:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9a3a773d3ec6324e385483c6a3dff882 |
Change in substantial holding
|
| 2018-02-07 09:13:00 |
Cancer vaccine shows early promise in clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8f4517b384e8b08c8983aab72e4844f6 |
|
| 2018-02-09 09:33:00 |
IMU Meets Investigator for Gastric Cancer Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/42706730e924ded912ba7a492757b417 |
|
| 2018-02-12 08:20:00 |
Novel Anti-PD-1 Mimotope Vaccine Ready for Development |
1 |
https://app.sharelinktechnologies.com/announcement/asx/acf37a13e18461800a64a35ac93457c3 |
|
| 2018-02-19 08:36:00 |
Arginine Modulator Active in Cancer Models |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d482cb0fc4c18f0654f7d541f8b6c450 |
|
| 2018-02-27 18:20:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f9783b0b71f88752b0663f601e4e7290 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2018-03-13 13:33:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1063108b3130b937db6681f95a04a34 |
Change in substantial holding
|
| 2018-03-13 17:29:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ef6b1a41c10711c9feba3cd82ec0343 |
Change in substantial holding
|
| 2018-03-28 09:03:00 |
Leslie Chong Appointed as Managing Director |
1 |
https://app.sharelinktechnologies.com/announcement/asx/edd26ef2482affcc37e2e9455bdb1f56 |
Director Appointment/Resignation
|
| 2018-03-29 17:08:00 |
Initial Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b54c9720a30a172bfb61c5c425dfdee4 |
Initial Director's Interest Notice
|
| 2018-04-13 15:21:00 |
Ceasing to be a substantial holder from PTM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a739c252d335963c2590a2d5498fc620 |
Ceasing to be a substantial holder
|
| 2018-04-26 15:41:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/51c5ac7e9981cfff412ab52832f7245a |
Commitments Test Entity - Third Quarter Report
|
| 2018-06-05 08:45:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/259b0b63ef6b5e8587588e3c38f3c767 |
|
| 2018-06-07 09:43:00 |
Imugene Licences Extensive B-Cell Immuno-Oncology Portfolio |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c21b4bf5178cc35ed1276120d2076c40 |
|
| 2018-06-07 09:43:00 |
IMUGENE RAISES $20.1 MILLION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e09d6421247b9060361a2001d374d945 |
|
| 2018-06-07 09:43:00 |
Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/10ebe1664eb29816d958a8e4254bfbb4 |
|
| 2018-06-07 09:43:00 |
Capital Raising Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6a8f7261b7f716bbd2a37255cab79f6 |
|
| 2018-06-07 09:43:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69bde07312a451de2c652ee5570f4a07 |
|
| 2018-06-07 09:44:00 |
Imugene Entitlement Offer notice to eligible shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01498cfa6f9751fcb7cf53e4d7a84592 |
|
| 2018-06-07 09:44:00 |
Imugene Entitlement Offer notice to option holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dda08196cead2ffedeb72a18feb69271 |
|
| 2018-06-07 09:44:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1569debef198cc04ea6c694ce7c0a1a2 |
Notice of General Meeting
|
| 2018-06-07 09:44:00 |
Imugene Entitlement Offer notice to ineligible shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a7fa09ff712cd91efcff51e5b198e1c |
|
| 2018-06-08 13:30:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/39f3947bb90ed14791acf4c5e7bdfb4b |
|
| 2018-06-14 09:51:00 |
Appendix 3B (Exercise of Options) and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4862dba3f06005c6cdb40dde4724b44b |
|
| 2018-07-06 10:48:00 |
Rights Issue Results & Shortfall Notification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/acd6baa7bfeeea5d1a6208df466e9f69 |
|
| 2018-07-09 09:49:00 |
General Meeting Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68b406ee5296890e9abbf3fe4b9e48f7 |
|
| 2018-07-09 10:10:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48084b251b8620dfeb947871a36899ea |
|
| 2018-07-10 10:32:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6e9e034b0caef89a22bc1efed51a6aad |
Becoming a substantial holder
|
| 2018-07-12 10:53:00 |
Appendix 3B and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/503db14991a3bee2b180bf374015034d |
|
| 2018-07-12 10:54:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed380582c283b553ecd3df633ded2e2d |
Change of Director's Interest Notice
|
| 2018-07-12 10:56:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc4a943de8ea0e753758acdd93b10bcd |
Change of Director's Interest Notice
|
| 2018-07-12 11:00:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0de90d4dd97f27c077b51dbd7a940ab |
Change of Director's Interest Notice
|
| 2018-07-16 08:19:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/305d3f1eb27a1e3072fadc3929d0d8ba |
|
| 2018-07-20 10:19:00 |
Appendix 3B ESOP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8154b031e511fc7c65f2931a2413b414 |
|
| 2018-07-20 10:20:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40a40be647495e8bc9a3e580d48262dc |
Change of Director's Interest Notice
|
| 2018-07-23 09:32:00 |
PD-1 cancer vaccine development update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8eb4b22687259b0b08feec5533149bf6 |
|
| 2018-07-24 15:07:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/679af75d1886bcf8cf662e06c542970f |
Change of Director's Interest Notice
|
| 2018-07-24 15:08:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1cef55c86f1c096d18e2e581029f6e3b |
Change of Director's Interest Notice
|
| 2018-07-27 09:54:00 |
2018 Bioshares Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64e09a4c487f87adcb1306b86cba1b93 |
|
| 2018-07-31 16:39:00 |
Appendix 4C - Quarterly and Business Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89a7e479b1b0f0950d12ef0365ecaccc |
Commitments Test Entity - Fourth Quarter Report
|
| 2018-08-23 09:20:00 |
Imugene appoints Dr Mark Marino Chief Medical Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/413f726a644938c7be44bad79f0b5dd4 |
Company Administration - Other
|
| 2018-08-31 16:31:00 |
Appendix 4E and Audited Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dcfc024e899c54b6cc21b37e98eae782 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2018-09-11 09:26:00 |
Imugene Completes Phase 1b Cancer Vaccine Trial Recruitment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4b2b643ed4a976a289be795eaedf25b4 |
|
| 2018-09-18 09:06:00 |
Imugene appoints gastrointestinal cancer expert to SAB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6de260a34deb3cacf7bf958f4dbe6224 |
Company Administration - Other
|
| 2018-09-21 08:29:00 |
Imugene commences cGMP manufacture of PD-1 cancer vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/97af6d7438fa577123e24eefb28fe9d8 |
|
| 2018-09-28 18:52:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1955cc3e902062bc4de677da8dc2a53c |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2018-09-28 18:53:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fadad491257290d49f22d9d6a3e30dc5 |
|
| 2018-10-01 09:18:00 |
Imugene appoints leading cancer researcher to SAB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf1d5ce42c232527d4c4af8e25b9e1a0 |
Company Administration - Other
|
| 2018-10-04 09:23:00 |
ESMO President joins Imugene Scientific Advisory Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0d20f28a12cd0986ccb1d8fb5fb5304 |
Company Administration - Other
|
| 2018-10-08 08:30:00 |
Change in Executive Remuneration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b202407d843ce3f2d25468426b689774 |
Company Administration - Other
|
| 2018-10-09 17:25:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f8a8797000d4650a795c1d117f450ec |
Notice of Annual General Meeting
|
| 2018-10-22 09:38:00 |
Appendix 3B (Exercise of Options) and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98c96747162f09c1957a7c4648bed390 |
|
| 2018-10-22 17:38:00 |
Change of Director's Interest Notice - AH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d507bf31608f949f70fef6f505c4dddc |
Change of Director's Interest Notice
|
| 2018-10-30 09:54:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0af30ba9ef0ed482faf18dd018d2955d |
Commitments Test Entity - First Quarter Report
|
| 2018-11-09 09:11:00 |
Imugene Receives $1.85 million R&D Tax Incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ba96c867a7df7d56c7ef0c6cfddaf053 |
|
| 2018-11-13 09:21:00 |
Imugene Advances to Phase 2 in Gastric Cancer Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b963f5d26cb74bba1b996614489dc36 |
|
| 2018-11-13 10:08:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc2998ba25175367b2e5fdf5c4d2ce35 |
|
| 2018-11-13 11:15:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c20650e26d1bab130f647dd4afcf73dc |
|
| 2018-11-21 09:39:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81f9aa905f9bddbbb689949951057e40 |
Change of Director's Interest Notice
|
| 2018-11-21 09:39:00 |
Appendix 3B and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f35f19b8a20b1c3291b38aa99684c451 |
|
| 2018-11-21 09:39:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4dc8006f3b942d96d901040768283ac |
Change of Director's Interest Notice
|
| 2018-12-17 08:25:00 |
IMU Meets Endpoints in Phase 1b Gastric Cancer Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c51313aed3a27d342a0c0938924df27d |
|
| 2018-12-20 14:13:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01e6f4a042e049bf45e754872cb746f7 |
Change of Director's Interest Notice
|
| 2019-01-07 09:37:00 |
IMU appoints distinguished scientist to the Company SAB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12567e247cd1840e26411eb76d55f5f8 |
Company Administration - Other
|
| 2019-01-10 09:22:00 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a3fbef9dbe9f20a307a2078f1f9d2f44 |
|
| 2019-01-30 09:28:00 |
Appendix 4C - Quarterly and Business Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2139eff80f648745a42cc26482e49f2 |
Commitments Test Entity - Second Quarter Report
|
| 2019-02-26 10:37:00 |
Clinical Cancer Research Journal publish B-Vaxx Phase 1 Data |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2d7c4038eb9605912cb86aea7f2d8d8 |
|
| 2019-02-28 09:08:00 |
Imugene Announces Presentation on HER-Vaxx at the AACR 2019 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7fcf00ed72e0f054c3ceb66c8281aa80 |
|
| 2019-02-28 09:56:00 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f5fc6784d36c57fc20da24fee4fbfcb9 |
|
| 2019-02-28 10:04:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0cd0938116291774e283d872079234ac |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2019-03-04 09:17:00 |
IMU Announces Presentations on KEY-Vaxx and B-Vaxx at AACR |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a840ab279145d25a51f5fc6740d1b961 |
|
| 2019-03-14 09:06:00 |
Imugene doses first patient in HER-Vaxx phase 2 trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9e7e77b56b2d55d10c1447b14829affe |
|
| 2019-03-20 09:03:00 |
IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx |
1 |
https://app.sharelinktechnologies.com/announcement/asx/80f6b345281c662ebcc9947728517885 |
|
| 2019-03-26 12:00:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92cacb7338158f68a1dfb8fccdc50bd1 |
|
| 2019-04-02 09:08:00 |
IMU presents positive new HER-Vaxx data at AACR |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4d1c56b1b9951709e196255fa4a29106 |
|
| 2019-04-02 09:44:00 |
IMU presents new KEY-Vaxx and B-Vaxx data at AACR |
1 |
https://app.sharelinktechnologies.com/announcement/asx/84e97ba6fe511caa28fa9b8d75fd1e95 |
|
| 2019-04-03 09:05:00 |
IMU presents new mimotope PD-1 vaccine data at AACR |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7e92d5f89fbfc08b7c7ed54da784aae |
|
| 2019-04-16 08:27:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec6ca6d8413e54200d62d457743b650d |
|
| 2019-04-16 09:27:00 |
Appendix 4C - Quarterly and Business Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7b1ce3601aaaf41fe7e601ba98b6ecda |
Commitments Test Entity - Third Quarter Report
|
| 2019-04-23 09:39:00 |
Leading Global Pharmaceutical Executive Joins Imugene Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/438ec21b15015ab51752b003ab515d79 |
Director Appointment/Resignation
|
| 2019-04-23 16:50:00 |
Initial Director's Interest Notice - LR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f61eb7fd511128d8260176d4e3a46072 |
Initial Director's Interest Notice
|
| 2019-04-29 09:15:00 |
New Cancer Vaccine Trial Data presented at ASCO 2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/faeda26b0f65afaee1e41fdb53fcd1ad |
Company Administration - Other
|
| 2019-05-01 11:37:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11460d464e7197b9db58418c6f18f51a |
|
| 2019-05-20 09:39:00 |
Global Biotechnology & VC Executive Joins Imugene Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18d61421e8d0a0e068de48c5040e0c6e |
Director Appointment/Resignation
|
| 2019-05-20 09:46:00 |
Initial Director's Interest Notice - JE |
0 |
https://app.sharelinktechnologies.com/announcement/asx/985c812a28f2f7cb2658cc20649cede7 |
Initial Director's Interest Notice
|
| 2019-06-04 09:16:00 |
Updated Phase 1b HER-Vaxx data presented at ASCO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84c25fd921fe5c08f58abcaa79a27704 |
|
| 2019-06-27 13:51:00 |
Appendix 3B and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a6ffbe031a5dd70b37b117bd89ae084 |
|
| 2019-07-08 09:13:00 |
New HER-Vaxx Cancer Vaccine trial data presented at ESMO GI |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2f61f7cc129fe921f0b9b9bcfe9a4463 |
|
| 2019-07-15 08:34:00 |
Imugene Enhances Portfolio with Compelling Oncolytic Virus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7f27234828e5710bfd72cfa312dd8044 |
|
| 2019-07-15 09:25:00 |
Investor Presentation - Proposed Acquisition |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0095979a35c8ad305cdb8359bc7f17a8 |
|
| 2019-07-15 10:21:00 |
Investor update call details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ddc4984d9dea4692b60929c8dcfbdb0 |
Company Administration - Other
|
| 2019-07-26 09:52:00 |
2019 Bioshares Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ff4cc8be8e9b27e94f4cce992fff310 |
|
| 2019-07-26 13:25:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/604dcaa2d1c7e00635a32ad778d81ece |
Commitments Test Entity - Fourth Quarter Report
|
| 2019-08-30 16:53:00 |
Appendix 4E & Annual Report to shareholders |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d90f238f484029356af2b4a293a181f5 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2019-08-30 16:56:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/256818056a747b7f8e74e36b3381a8de |
|
| 2019-08-30 16:57:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a97b65ad2362f61620864ac09890258 |
|
| 2019-10-01 09:19:00 |
Comprehensive Phase Ib HER-Vaxx Results Presented at ESMO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/11227a41750af5c792054745f60664ae |
|
| 2019-10-01 09:30:00 |
Imugene Cancer Vaccine Combinations Presented at ESMO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1286d0699e3b6720a8a44349e07373c |
|
| 2019-10-04 12:35:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/390b7a791ed67da3c9c8400ec8691fad |
Notice of Annual General Meeting
|
| 2019-10-04 14:57:00 |
Share Sale Facility for Holders of Unmarketable Parcels |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f4fe5fcdbcb3049250314c707668ccc0 |
|
| 2019-10-09 11:08:00 |
Notice of UMP Facility to Eligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0158f8116680532ff894bb728c5270d |
|
| 2019-10-14 16:40:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bf61fd3ec08c5611c8a2cab2bd64553 |
Notice of Extraordinary General Meeting
|
| 2019-10-17 10:26:00 |
Yuman Fong, MD to Chair Imugene Oncolytic Virotherapy SAB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c34b9a5f273ca6fd5be02dce0f287ad8 |
Company Administration - Other
|
| 2019-10-18 11:04:00 |
Appendix 3B and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f6e04fdcb9d6e64eda66e5eff7b127af |
|
| 2019-10-21 09:15:00 |
CF33 Oncolytic Virus Clinical Trial Program Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c9fbe67d8c9e511f52bdcdec9335cfe2 |
|
| 2019-10-21 15:09:00 |
Change of Director's Interest Notice - AH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c2bc12e6f2541442d25d34045fb2aa7 |
Change of Director's Interest Notice
|
| 2019-10-23 09:44:00 |
US Defense Grant to Study Imugene CF33 Oncolytic Virotherapy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/558f6fdb6327d77da27698f703d94476 |
|
| 2019-10-25 16:34:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ce445509f6d66df5cf9eb49a087c449 |
Commitments Test Entity - First Quarter Report
|
| 2019-11-04 14:52:00 |
Imugene Receives $4.13 million R&D Tax Incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/40c8dc369a9ec088c8dbd89cf1d11020 |
Company Administration - Other
|
| 2019-11-06 12:08:00 |
Investor Presentation - November 2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5a6311998a1e4a615305d08575262ae |
|
| 2019-11-07 11:10:00 |
Imugene Annual General Meeting Call Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0639b517400f982b5073c0c150d6691 |
Notice of Meeting - Other
Company Administration - Other
|
| 2019-11-08 10:41:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de46b1d2b971d20fbc1fd0cb0e0f036b |
|
| 2019-11-08 11:51:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19591b8234a53e4e7d40782f291d151f |
|
| 2019-11-11 13:50:00 |
Imugene Extraordinary General Meeting Call Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3ab383931c53949b67eda9d35a6c81e |
Notice of Meeting - Other
|
| 2019-11-15 16:32:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdd6a4f8f9f3fe8ed59b6735f07eb03f |
|
| 2019-11-18 11:05:00 |
Results of Meeting - Oncolytic Virus Acquisition Complete |
0 |
https://app.sharelinktechnologies.com/announcement/asx/620fe683d8a32c09f25138a8c2f07a2a |
|
| 2019-11-19 15:43:00 |
Change of Director's Interest Notice - AH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2dbc9197137e87ab2e44939659babaf1 |
Change of Director's Interest Notice
|
| 2019-11-19 15:44:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07f23d5e8fcc3f6860942723847cc8d8 |
Change of Director's Interest Notice
|
| 2019-11-19 15:45:00 |
Change of Director's Interest Notice - JE |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1113e4cf3131aef7a7c1224af2c7fab |
Change of Director's Interest Notice
|
| 2019-11-19 15:45:00 |
Change of Director's Interest Notice - LR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6796fcb958fd18e77a8ec5b7fc3cec03 |
Change of Director's Interest Notice
|
| 2019-11-20 08:40:00 |
Imugene appoints Prof Prasad S Adusumilli of MSKCC to OV SAB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b69b080dcdf945f5c8630bfefdd36a1 |
Company Administration - Other
|
| 2019-11-25 08:14:00 |
CF33 Oncolytic Virus GMP Manufacturing Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/491ba630d2eaf436ea8909c0cfa98e6a |
|
| 2019-11-27 18:52:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0630e0f88ecc16dd13cd1f3dc673bc64 |
Change of Director's Interest Notice
|
| 2019-11-28 08:50:00 |
Appendix 3B and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4d150e23320061352ad9bbe3a2d7c6b |
|
| 2019-11-28 09:02:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2841c77503a23948287a67d5b716e01d |
|
| 2019-11-28 16:54:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b35c91afd769abff47f5d54fae400a07 |
Change of Director's Interest Notice
|
| 2019-12-02 09:54:00 |
Imugene Share Placement to raise $24.6 million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/522f2dca6e0f17a1eb9b40eb7d382d4e |
|
| 2019-12-02 09:57:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e401cfcc8c45d2b9d07969f6a0cdb353 |
|
| 2019-12-02 17:47:00 |
Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9315f796a3cb26d5725268b015cbbe81 |
|
| 2019-12-05 08:54:00 |
Imugene appoints Dr R Auer to Oncolytic Virotherapy SAB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26be6e45965801546215a260c2b4e5a4 |
Company Administration - Other
|
| 2019-12-06 17:41:00 |
Appendix 3B and Required LR 3.10.5A Information |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c3c2b9ebbd35e1e7df178f344f1cf4b |
|
| 2019-12-24 12:56:00 |
Completion of Less Than Marketable Parcel Sale |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7774dbb108d06363aa141c4aceaff72f |
|
| 2020-01-14 09:46:00 |
Imugene HER-Vaxx Immunotherapy Patent Granted in US |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ebd0bfac3ea822bf72b2ddf4d5e48f8 |
|
| 2020-01-28 09:17:00 |
Imugene PD1-Vaxx Immunotherapy Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b54da9809cfc2cf3610bfe6c7449b574 |
|
| 2020-01-31 10:05:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/34058a43f51aa8f87cf11e6459d1333b |
Commitments Test Entity - Second Quarter Report
|
| 2020-02-13 17:25:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8bc5536c251937b9a2df22577d6f06c1 |
Ceasing to be a substantial holder
|
| 2020-02-26 18:47:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/02beb6ba288045084551a2de5fd82f5a |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2020-03-11 11:14:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d607c01014666331750427e3c18ba28 |
Change of Director's Interest Notice
|
| 2020-03-13 10:07:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad30c9ff7d60b53dd7ca8b54288a1755 |
Change of Director's Interest Notice
|
| 2020-03-17 09:34:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1ad99c7ee71a4eadf2c5cd1a442edbe |
Change of Director's Interest Notice
|
| 2020-03-18 09:20:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/246cf45997f0a4dcf25df62dd6bb9e96 |
Change of Director's Interest Notice
|
| 2020-03-25 11:36:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a08399e0162f0b9828a7ad120470ade |
Change of Director's Interest Notice
|
| 2020-03-30 10:47:00 |
Change of Director's Interest Notice - LR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/700f9f68642ea77b6f9fabae63cd1b4a |
Change of Director's Interest Notice
|
| 2020-04-24 12:35:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8ee4f7ab89696cef4cf781b3e7dfbb2a |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2020-04-27 14:08:00 |
IMU Presents Vaxinia Clinical Plan at AACR Annual Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c16d24a62547ba5c2004a1bf0cd2e116 |
|
| 2020-04-27 14:08:00 |
IMU Presents PD1-Vaxx Clinical Plan at AACR Annual Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97b602bf6c793a561e67fc3d30a25b2f |
|
| 2020-05-04 09:08:00 |
Imugene HER-Vaxx Phase 2 Clinical Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a48e785ef64ac140c08d23dc999b7c33 |
|
| 2020-05-15 16:46:00 |
Release of Securities from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81a6957739592abf4f5d7526f3512fd1 |
|
| 2020-05-28 12:22:00 |
New mimotope cancer vaccine results published |
0 |
https://app.sharelinktechnologies.com/announcement/asx/984934507a1bf1d1f6580c39abc15fcc |
|
| 2020-07-14 09:14:00 |
Imugene Receives Ethics Approval to Start PD1-VAXX Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3bbc6c3390846f38138cf187404ecd7d |
|
| 2020-07-17 09:13:00 |
Imugene Receives Second PD1-VAXX Ethics Trial Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/71c88cfc6b0496a4c5ca824f4dc811f4 |
|
| 2020-07-27 10:54:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f96d1dde14ac78c7522f8dc18cea217 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2020-08-04 15:38:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e37524bfe1486746108f97aa6c7087b9 |
|
| 2020-08-05 11:25:00 |
Appendix 2A and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7dd891dec79d31980646189c499a0779 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-08-05 12:40:00 |
CEO and Managing Director increases shareholding in Imugene |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f261da05e3900c02babec61f5c304165 |
Security holder details - Other
|
| 2020-08-05 12:44:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/354fad1e57234fa12426d1873e35e4be |
Change of Director's Interest Notice
|
| 2020-08-06 08:49:00 |
Imugene Receives Clinical Guidance from US FDA for Vaxinia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d5e32d2bf46bddf65fdd7f6248a8c26f |
|
| 2020-08-07 10:30:00 |
Letter to IMUOA Option Share Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf7593e67d45db24ad83dab1d259a702 |
Letter to Shareholders - Other
|
| 2020-08-07 16:14:00 |
Change of Director's Interest Notice - CW & AH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3b280cf31a7b71c529a2e4d05f41fe6 |
Change of Director's Interest Notice
|
| 2020-08-12 16:47:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8edbd5f24bf6d80445d08ffd26ddb218 |
Change of Director's Interest Notice
|
| 2020-08-18 15:12:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8421626a5e6594f13f0e7265a2a14ea |
|
| 2020-08-18 17:43:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94c24db40ba2593f46a60840304376d5 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-08-21 09:00:00 |
Imugene Receives Third PD1-VAXX Ethics Trial Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4c902e9690b5523e44ce60ca04624d3e |
|
| 2020-08-25 17:25:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0635082a084b05b18d04ce462679a922 |
|
| 2020-08-25 17:37:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b400308f204386c6bc287de0ba4ff816 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-08-31 18:03:00 |
Appendix 4E & Annual Report to shareholders |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8a8e8f052ee29846b9af0db4c029b6c |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2020-08-31 18:04:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd4feb1516752f2c6d3d5d26dd13f975 |
|
| 2020-08-31 18:04:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e738389f0d0c8bd3b52266ce166faf8f |
|
| 2020-09-01 17:49:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/47f1321a3891972ec3ee0bc728caff64 |
|
| 2020-09-01 18:36:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4ca7bfa0878fcd6ff89f4513751cc9d |
Appendix 2A (Application for Quotation of Securities
|
| 2020-09-03 14:52:00 |
Imugene Receives PD1-VAXX Ethics Trial Approval in USA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1ccef2fb52064229337d57672160997e |
|
| 2020-09-09 09:15:00 |
Imugene Secures $5.7 million Option Underwriting Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1d09fc8afccda2f87a0f6cf0877ced5c |
|
| 2020-09-09 18:15:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/14957a9001bca4c7e7e60a195a4523e8 |
|
| 2020-09-09 18:41:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8fb878d99f40233d2cda482ef9461481 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-09-23 19:02:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2968796a17edb1c14bc6b86e98ef9c9 |
|
| 2020-09-23 19:22:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c54949bb66c7d94204b72696e86bf717 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-09-30 08:57:00 |
Imugene appoints Dr Rita Laeufle as Chief Medical Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca8ce767c6129257727818979028cdd0 |
Company Administration - Other
|
| 2020-09-30 16:34:00 |
Letter to IMUOA & IMUOB Option Share Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/262a6ba073b0ecd198e8d9fc50db9675 |
Company Administration - Other
|
| 2020-10-02 08:37:00 |
Imugene Immunotherapy Combination Patent Granted in US |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4e304f37b93f2707ca2ed6db6b2a452f |
|
| 2020-10-07 19:11:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fef2092e6eb708a65f36e6f933ad3093 |
|
| 2020-10-07 19:30:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3ec26b2b9c10869a72b4fc5291ac870 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-10-15 16:53:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d399f18f091c9d307cd14f30992ecc8d |
|
| 2020-10-15 17:06:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc5cea78da85bcff9ea054b851a7df73 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-10-21 17:04:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/847f07b125ccb5b85027fe7727748411 |
Notice of Annual General Meeting
|
| 2020-10-22 18:43:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1babf2fc09cd7baa39e98e5b1e15b2e |
|
| 2020-10-22 18:50:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6e345f50f437335bd2f55b115d2cfb37 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-10-27 09:47:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc105b2038470faca3e4cf84da4ea04d |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2020-11-02 08:51:00 |
Imugene Receives FDA IND Approval for PD1-VAXX Trial in USA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2928edf0905d1c94bd2e2b256d7b25ea |
|
| 2020-11-02 17:35:00 |
Letter to IMUOA Optionholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c79e19c89c4bdb6f2371a0c393b66c5 |
|
| 2020-11-04 13:59:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d1f0a30036ba46a5711691ab094aff0e |
Becoming a substantial holder
|
| 2020-11-04 17:24:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc4a4c67dcc72be1b92558b81c1eca6e |
|
| 2020-11-04 18:10:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64678165bbdd4d6705af5cded84d9e35 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-11-10 18:08:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1ceb53102f0a904528507126cf66d38 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-11-10 18:16:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30f5bd23bd84bc564c434da4a9248e65 |
|
| 2020-11-17 19:00:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/928d8fba248739e756fc2beae55cc2f3 |
|
| 2020-11-17 19:16:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97f11ad54f72b4c1ee6e66cc74875946 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-11-18 11:54:00 |
Release of Securities from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/afcefa38a0fc2b3674a8f0a3dd03f4c3 |
|
| 2020-11-23 08:21:00 |
Imugene HER Vaxx shows positive Overall Survival in trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/93e026fb72524e10c76bea0e18de3f9c |
|
| 2020-11-24 08:24:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d447964d2f2e486f50fdc6ae5523832f |
|
| 2020-11-24 08:24:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb967d765cc27ed3aaed63d6942a94ed |
Chairman's Address to Shareholders
|
| 2020-11-24 12:15:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ace4f35ff994440629cf629313a62520 |
|
| 2020-11-24 19:27:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/489563564beb4a00bcd83ebc68e83a6d |
|
| 2020-11-24 19:39:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee70699666305a11512c61959e83674d |
Appendix 2A (Application for Quotation of Securities
|
| 2020-11-27 16:06:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b73259c5e0ee297666f3803538545549 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-12-01 08:33:00 |
Imugene First Patient Dosed in PD1-VAXX Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6337f4c33f0d4ef51584a4e502ffc567 |
|
| 2020-12-01 19:46:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a68ac8e29401f0afa2992016dedaf65 |
|
| 2020-12-01 20:11:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73c416839631b264209a5c4792d11e0c |
Appendix 2A (Application for Quotation of Securities
|
| 2020-12-03 19:37:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef448e9e2fc3025babd4435f0c15fcdd |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2020-12-08 14:01:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f9525d6148047e585c3a7587fcfc20e |
Change of Director's Interest Notice
|
| 2020-12-09 19:38:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7257ee71cd88113e6f64eecf3eb4a5d7 |
|
| 2020-12-09 19:51:00 |
Appendix 2A and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e02d9dbae8c382e075797e213e188366 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-12-10 13:27:00 |
Imugene Receives $4.82 million R&D Tax Incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d069a84977f6edbfa79e70c08a068dae |
|
| 2020-12-16 12:36:00 |
Changes to Executive Chairman Remuneration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1208e8868de80219605967beddc424d7 |
Company Administration - Other
|
| 2020-12-16 19:37:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6882192e270f54fb10ab8d393ea803a1 |
|
| 2020-12-16 19:38:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9baa47de041beaf6261548a1920d65fa |
Appendix 2A (Application for Quotation of Securities
|
| 2020-12-16 19:39:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7b7432d7e1218c455c78bcb28d51f2b5 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2020-12-17 09:04:00 |
Imugene Enrols First Cohort of PD1-Vaxx Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b8dcfb5655a80f03d51a0d89a183d540 |
|
| 2020-12-17 16:34:00 |
Change of Director's Interest Notice - AH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fcb16cd1dd913692826b4a3a1ee0354b |
Change of Director's Interest Notice
|
| 2020-12-22 18:11:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d2a94acd9b6d5281f259760119d8334 |
|
| 2020-12-22 18:13:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/feadaedd530c5c46603b4810b5b2cd23 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-12-23 09:18:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b89634b93b84760939b375790f560db |
Change of Director's Interest Notice
Company Administration - Other
|
| 2020-12-23 10:01:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a49908a853e7577b0cddf8bfe95cdfe |
Change of Director's Interest Notice
|
| 2021-01-07 09:43:00 |
IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2b72c73a1fe722a2b6f1e8b011f67f89 |
|
| 2021-01-21 10:23:00 |
Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ef77d27fbee61e7648df2435360024c9 |
|
| 2021-01-27 18:50:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d4f1d58fcef39943420c1caf306fb05 |
|
| 2021-01-27 19:12:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5afb3d5cbc9f186ae22271f3c52ad1a1 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-01-29 09:59:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/58f29d302963d5eda1cb797689e2f35c |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2021-02-03 18:44:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/993a29d435c1de7b8768894f171bdc92 |
|
| 2021-02-03 19:06:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b51542eb2540f9989d25138ae86dd76 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-02-12 08:41:00 |
Imugene Commences Cohort 2 Dosing in Phase 1 PD1-VAXX Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57b0db5cef7d29fdbbff14c2c065c264 |
|
| 2021-02-23 17:14:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79aa2d541cc76f736340d07a7d70aa8a |
|
| 2021-02-23 17:17:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/66440d7e8ef0e8a34b4b6611ad716515 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-02-26 14:46:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/03fa59d9edb2c34c383cf48a2a0289a1 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2021-03-11 09:29:00 |
Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea0ab414163a5ea5b532c030a0331190 |
|
| 2021-03-11 09:43:00 |
Imugene to Present Oncolytic Virus Data at AACR21 Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5704563a4c4759f618778a7fbc106921 |
Company Administration - Other
|
| 2021-03-12 17:00:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c26a5c54251d3a5a4dff2a3bd33c856 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2021-03-12 17:02:00 |
S&P DJI Announces March 2021 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c4537e50aec7075a471239bf8c2eda5b |
Standard and Poor's Announcement
|
| 2021-04-01 16:56:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6d0fd835d1b8d67f7f606171bad6151 |
|
| 2021-04-01 17:35:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f839e739ddaa59a5dc4936f4be844305 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-04-07 09:23:00 |
Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX |
1 |
https://app.sharelinktechnologies.com/announcement/asx/32fb00cbfec3a0bff134a5aefe14340c |
|
| 2021-04-12 08:37:00 |
Imugene HER-Vaxx Presentation at AACR 2021 Meeting |
1 |
https://app.sharelinktechnologies.com/announcement/asx/23760c163f9b7ff20ff5c698bd528fb6 |
|
| 2021-04-12 08:41:00 |
Imugene Oncolytic Virus Presentation at AACR 2021 Meeting |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b791b0850ca2dcbdb65b1fd8b63dda32 |
|
| 2021-04-19 17:09:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0f65e2e0fee9e3d2747448e67535ecf |
|
| 2021-04-19 17:15:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/62735486e289e2168fdfbdcd59ba5693 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-04-21 09:37:00 |
Imugene announces clinical milestone for HER-Vaxx |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8eeddded590279d1b2d43613a4605945 |
|
| 2021-04-23 13:50:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d5c466409eb59e9be95362afabb93819 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2021-04-29 10:15:00 |
Prestigious Research Journal Publish HER-Vaxx Phase 1B Data |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d5f72b327106f6809c947ece5147a68e |
Company Administration - Other
|
| 2021-04-29 18:05:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a756a3198086e1f6c10f03cf656ec36f |
|
| 2021-04-29 18:10:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85ad87a1e43e98d341fcdbd8a49294bd |
Appendix 2A (Application for Quotation of Securities
|
| 2021-05-07 18:09:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3880117df1f40de36045d9c63468076 |
|
| 2021-05-07 18:18:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3956298a9ca7ee2d1aa8d0ed2630184 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-05-14 17:05:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/411c7b31569ff9246abce407c2d51c4a |
|
| 2021-05-14 17:07:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c0e348a0dbeb581da956fca27d8827a |
Appendix 2A (Application for Quotation of Securities
|
| 2021-05-18 08:22:00 |
IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d58c5a5c693cd103c43217322980d6a1 |
|
| 2021-05-18 08:34:00 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98846b15d66c10d77aaefd947c429bb3 |
|
| 2021-05-18 08:38:00 |
Investor Webinar Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f4b51b0f0a9f07097cd36531a9ea481 |
|
| 2021-05-21 16:41:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87ca94aa6f3cbba58c6d99a418a37ab2 |
|
| 2021-05-21 16:45:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12b62b93279bafde9f21720c94de41ab |
Appendix 2A (Application for Quotation of Securities
|
| 2021-05-25 10:23:00 |
CEO & Executive Chairman increases IMU shareholding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ca9ac4ff5cb8c2bc2ecf25c4fd6af8e |
Security holder details - Other
|
| 2021-05-25 16:18:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59556f50686b540fb698b3f6add78b74 |
|
| 2021-05-25 16:25:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b50e4236453042b94fbb14ab5fdd1cff |
Appendix 2A (Application for Quotation of Securities
|
| 2021-05-25 17:13:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0b660329b4cf354d4460f2189e6a6c7 |
Change of Director's Interest Notice
|
| 2021-05-25 17:18:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f6855342e84b3bcab0cb61e299b1fb9 |
Change of Director's Interest Notice
|
| 2021-05-27 16:58:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d18e8f01f4cd027cd91390aa7b8d7e00 |
Change of Director's Interest Notice
|
| 2021-05-28 09:46:00 |
Managing Director and CEO increases shareholding in Imugene |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a820135ef7480d9d76851d76cf8fffe |
Security holder details - Other
|
| 2021-05-28 16:46:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87a1cd09232806f3acaeda83f9a3e9da |
|
| 2021-05-28 17:21:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00bd3228d3e974149e398a20ea12e6e8 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-05-28 17:23:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb1e7178ef3b11d7377bf107538e3e6e |
Change of Director's Interest Notice
|
| 2021-06-04 16:36:00 |
Proposed issue of Securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d914e991e0f36d5407a6c4942be54846 |
|
| 2021-06-04 16:42:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93dbb7742b6bfb05c2253f5e17898c83 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-06-10 08:56:00 |
Imugene Appoints Dr Monil Shah as Chief Business Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1307d2de0d6f6b1fc74dd950b984be35 |
Company Administration - Other
|
| 2021-06-11 09:22:00 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b7a50a720a284060cf3133754fae667 |
|
| 2021-06-11 10:53:00 |
Investor Webinar Presentation Clarification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f336ad0a9030bdc5c93ae0ab70a43f2 |
Company Administration - Other
|
| 2021-06-11 12:56:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe5a1684c206b8812dcc3cf84ddf78fc |
|
| 2021-06-11 17:58:00 |
Proposed issue of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e728d53ed758586390b9803f70697606 |
|
| 2021-06-15 14:43:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f0d22519279c332a3f774d104325e80 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2021-06-15 14:55:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d798081a9a547d0b02a1a053f6f87ccc |
Appendix 2A (Application for Quotation of Securities
|
| 2021-06-15 15:07:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07f6ff593e16ed5e926bda17b7715787 |
|
| 2021-06-25 15:27:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13c1cabb07866401cfd5392228d56ac3 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-06-29 16:27:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ef382b7ba26285b7b2fb34e4c138066 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-07-02 08:26:00 |
FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d4a8f9d96bd868ad44f05168f021d2c6 |
|
| 2021-07-05 08:55:00 |
Imugene Presents HER-Vaxx Update at ESMO World GI Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f6d90705487887c6fd0127fcfcfd0289 |
|
| 2021-07-05 16:18:00 |
Change of Director's Interest Notice - LR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4bf2d9ebc6e32cd11f4b7c36b79c2541 |
Change of Director's Interest Notice
|
| 2021-07-09 12:20:00 |
Issuance of Milestone Shares Under Vaxinia Acquisition |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da6634333715dab301fb8484579a2484 |
|
| 2021-07-09 15:27:00 |
Proposed issue of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ec08472ecf9625e05707f002cc9ae5c |
|
| 2021-07-09 18:28:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e616d74c4433ce9bcfcb12dbedcfb9eb |
Appendix 2A (Application for Quotation of Securities
|
| 2021-07-09 18:32:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/96e2698d8532535d067a3dd1388b9e67 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-07-09 18:40:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19bb9bbfc5ec329b20e32355db09e6b1 |
|
| 2021-07-23 12:03:00 |
Appendix 4C - Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e3e4773fe3900b886f56716d107a1227 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2021-07-26 15:54:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/005bdd23ef01ae2cf0025f0efaea2495 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-07-27 08:44:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a35052cac3d7144fa1a3773142a09eb5 |
|
| 2021-07-28 18:51:00 |
Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b7c09e1378af2ff4d646dfb6390d2cdb |
|
| 2021-07-29 09:18:00 |
Imugene completes $90 M placement and launches $5 M SPP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/30cd0c5d94a228b60cbe50358a678deb |
|
| 2021-07-29 09:19:00 |
Imugene Capital Raising Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c312a7f0393c4e4481f4fb16ebc466b5 |
|
| 2021-07-29 09:20:00 |
Proposed issue of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3798d9af9df99fba20a297da2e1f1ef |
|
| 2021-07-29 09:22:00 |
Proposed issue of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/260d0cd3efb20d3162b64286291b8019 |
|
| 2021-07-29 10:30:00 |
Prospectus for SPP and Placement Options Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e7cad5263760fc18d26efdc299319acf |
|
| 2021-08-02 15:15:00 |
Imugene to present at NWR virtual investor conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46d22e7698484ce33de998b594ad8549 |
|
| 2021-08-04 12:04:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f710cf2bbb8fb88890682016054d2608 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-08-04 16:45:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cea5a35c9ec2ff3b87a074563d1a667 |
|
| 2021-08-05 08:23:00 |
Research partnership with Celularity for solid tumors |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d1a287a5bd58fbb459e7b1c631abf3f5 |
|
| 2021-08-05 08:24:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3deff7a68da31ee422a3fa0253b618a |
|
| 2021-08-05 08:25:00 |
Imugene Investor Webinar with Celularity Dr Robert Hariri |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e687c75e5aad647fb5aa088ae6596608 |
|
| 2021-08-06 10:52:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ebe520d68cfd050b9862e674385826c |
Notice of Extraordinary General Meeting
|
| 2021-08-10 09:43:00 |
Further Information on Partnership with Celularity |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3c55407df036f4e75a691caaddc887f |
|
| 2021-08-13 17:43:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4fb27a7dd2c804c2240d41140e766b2 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-08-19 17:56:00 |
Results of Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe6707ca2180da809c9f46c444e43445 |
|
| 2021-08-20 11:34:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b09753970cfa368ab05b52e447a2d8f3 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-08-23 14:12:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d4dbec0c68403019b1de22aedf58b740 |
|
| 2021-08-27 08:11:00 |
Phase 1 Clinical Trial Update of Immunotherapy PD1-Vaxx |
1 |
https://app.sharelinktechnologies.com/announcement/asx/83221fd4c1b895c5f28ed164bbbc3d70 |
|
| 2021-08-27 11:07:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f8dbde5cf215b4797c34cbc1d94e62d |
Appendix 2A (Application for Quotation of Securities
|
| 2021-08-30 12:16:00 |
Appendix 4E and Full Year Statutory Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4952a1d0bd335ddb81dc657ef905b143 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2021-09-01 09:07:00 |
Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89c8d2632f4042d2ebeb318143bc2c37 |
|
| 2021-09-03 15:01:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ffa9575bda9dd976aa7ced2c8a18909 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-09-03 17:10:00 |
S&P DJI Announces September 2021 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c7be07f7d7238851e24c1c3cda7c0df8 |
Standard and Poor's Announcement
|
| 2021-09-07 10:04:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/841ebd846c8afae24b6758370ee870d6 |
|
| 2021-09-07 17:53:00 |
Proposed issue of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97c2d8a3508fbcd0918823fcfe7e09c9 |
|
| 2021-09-09 12:09:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e02ce662f7ef755d8339f419ec8a3b20 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-09-13 09:56:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c8f1588a8e9b7fe510300e17a3932dd |
Change of Director's Interest Notice
|
| 2021-09-13 10:03:00 |
Becoming a substantial holder - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/620c75ac333669054c65f2e5424f2aab |
Becoming a substantial holder
|
| 2021-09-13 12:04:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79d1b212db88aa5277fffec283ca33f1 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-09-17 09:20:00 |
PD1-Vaxx Presentation at ESMO Congress 2021 Annual Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/123674a9ff8f8ef41935e156da860bf0 |
|
| 2021-09-17 15:01:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bdecd1dd1b1316f1c67075b4975e609 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-09-22 09:26:00 |
Imugene HER-Vaxx Immunotherapy Patent Granted in Japan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/db316cbb8dfdce083e451006fadb932e |
|
| 2021-10-01 13:07:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ff7a2dcbf836f13f0f2751089766a7b |
Appendix 2A (Application for Quotation of Securities
|
| 2021-10-04 13:30:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88c4f7b84cfd053641f29f27d072bc3d |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2021-10-04 13:31:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee1f88f5cba3dfbaa15b6ad14d1e9682 |
|
| 2021-10-04 13:32:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20a2f5b3ad6bf689169fa269f7567570 |
|
| 2021-10-05 17:07:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/558bb1ddef14b5d322169f0d4e23f3f7 |
|
| 2021-10-08 12:15:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5514c40ad262ae0bc3ad98e4117bd6c0 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-10-11 16:41:00 |
Change of Director's Interest Notice - LR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/079234bacec050e35a1d0ccb0fcb0dc2 |
Change of Director's Interest Notice
|
| 2021-10-14 19:34:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa61e18eafd7e1b6c46480784e6eccea |
Notice of Annual General Meeting
|
| 2021-10-15 16:10:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2beaf7b6df2ea5e26a925edcafa7d4a9 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-10-20 12:42:00 |
FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF CHECKVACC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f027f0e0693c886137f017c5f3bc12ea |
|
| 2021-10-20 18:09:00 |
Proposed issue of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d48bc9c55a075f2024d3ad2b8a2abd5 |
|
| 2021-10-22 16:56:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89692939f33cdcc2ed20f45b2f5dd78c |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2021-10-22 17:31:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dcce716aad0eb5b383c1bd067406e5a2 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-10-22 17:36:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8ccdfc544e4e83ae4d071fc81d55d65 |
|
| 2021-10-22 17:40:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1bacdc9d6ce54e13cd71ec0bba2451d7 |
Change of Director's Interest Notice
|
| 2021-10-22 17:43:00 |
Change in substantial holding - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b70fc8ba929e2690aa509ab475aacc58 |
Change in substantial holding
|
| 2021-10-25 17:34:00 |
Letter to IMUOB Optionholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/761828c3ea7b8c308c778d72b842365d |
|
| 2021-10-25 17:57:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef3b8931b52aec2486c0ca4d7b8d5185 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-10-29 19:08:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a461b337c14bde8d231818ebbcfb2d1a |
Appendix 2A (Application for Quotation of Securities
|
| 2021-11-01 08:11:00 |
Imugene and Eureka Therapeutics onCARlytics Collaboration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4644403e5646f5a7935913f9c30e029e |
|
| 2021-11-01 08:20:00 |
Investor webinar Imugene & Eureka Therapeutics Collaboration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/913c182ef2578fed0d2c6c2f18c3b7a8 |
Company Administration - Other
|
| 2021-11-01 08:35:00 |
Investor Presentation Imugene Eureka Therapeutics |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a2b8efd1cd016da223ede87d3e67106c |
|
| 2021-11-05 17:13:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2730b5e1d29d25633c0e8d3607d9d55 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-11-09 19:26:00 |
Eureka Strategic Collaboration (supplementary announcement) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8ff3993960ad95344c5a11ca530425a |
Company Administration - Other
|
| 2021-11-12 17:05:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b25b762dc340fa6be609776b66a45499 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-11-16 08:15:00 |
Clinical Trial Supply Agreement with Merck KGaA and Pfizer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dc3bc94ee042816b320df39555b60ab4 |
|
| 2021-11-16 17:38:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0002045be406b7400e94149c8d8cd64a |
Appendix 2A (Application for Quotation of Securities
|
| 2021-11-16 17:44:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76011195bcd0cafc4f834519a55e6a18 |
|
| 2021-11-19 10:34:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca51ee197616669b1e7f147c22e9a2cd |
|
| 2021-11-19 17:41:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f3346c9257bb7620b2e5441fb062e19 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-11-19 18:14:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c31825e740b4021dc31df30eba95dc1c |
|
| 2021-11-22 09:02:00 |
Change of Director's Interest Notice (AH) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/39cbefc67ef65f9be85d6bad3282e32b |
Change of Director's Interest Notice
|
| 2021-11-22 09:09:00 |
Ceasing to be a Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e39340d4a30a725ca826478da5342f84 |
Director Appointment/Resignation
|
| 2021-11-22 09:10:00 |
Final Director's Interest Notice (AH) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6af35ab12b037ec9101f250ea17e3e8e |
Final Director's Interest Notice
|
| 2021-11-23 08:52:00 |
Results of Meeting Percentages |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e2fbefdf0c81a9701833c6c808eb9a50 |
|
| 2021-11-26 19:07:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/653a9f0e3dafd60eb8c9dff58697a7ed |
Appendix 2A (Application for Quotation of Securities
|
| 2021-12-03 17:00:00 |
S&P DJI Announces December 2021 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7bc70cdea8eff35265ddaf2c8b490d3a |
Standard and Poor's Announcement
|
| 2021-12-06 08:33:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ae8f5dd32156a13c125f94784bee8cd |
Appendix 2A (Application for Quotation of Securities
|
| 2021-12-07 08:50:00 |
Update on Clinical Trial of Oncolytic Virotherapy CHECKvacc |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e567996df6817ae54d16fb94baa1f872 |
|
| 2021-12-08 17:03:00 |
Change in Joint Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b3be2c0a9bd941ac6f4a87c6856315c |
Company Secretary Appointment/Resignation
|
| 2021-12-10 17:31:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a0ef7a9a4d21aafa6225415ef74209c |
Appendix 2A (Application for Quotation of Securities
|
| 2021-12-13 08:47:00 |
FDA IND APPROVAL FOR ONCOLYTIC VIROTHERAPY VAXINIA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c50aad84c36fbe401cb5fc7e8ed8d0f1 |
|
| 2021-12-13 08:47:00 |
FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX |
1 |
https://app.sharelinktechnologies.com/announcement/asx/615e94aad0414d465f37558b7f6bc769 |
|
| 2021-12-13 18:42:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d6527e631a6699ada149730ef85f782 |
Change of Director's Interest Notice
|
| 2021-12-14 09:38:00 |
Imugene HER-Vaxx Immunotherapy Patent Allowed in China |
0 |
https://app.sharelinktechnologies.com/announcement/asx/08cd082c8ecc1d0d7bfc28be90da09f9 |
|
| 2021-12-15 17:58:00 |
Change in substantial holding - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53f2103ee916d45768c6d7d048b8881d |
Change in substantial holding
|
| 2021-12-20 09:25:00 |
Appendix 2A and IMUOB Option Underwriting Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83f045aca25c172bc036106ad6288e81 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-12-20 16:51:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/142fc3273a9d728d731b4356251482ef |
Change of Director's Interest Notice
|
| 2021-12-23 16:58:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64a8739364132eb9c2e5822dabb70506 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-12-23 17:11:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87a110631319ec60d4970d7cfcfb549a |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2021-12-23 17:14:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31bc4b784c239fd04e28d1c470aa77a3 |
|
| 2022-01-04 09:27:00 |
Imugene adds industry leaders to senior management team |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b05b854d431ff761f1d52beb2f2c0101 |
Company Administration - Other
|
| 2022-01-04 09:30:00 |
Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx |
1 |
https://app.sharelinktechnologies.com/announcement/asx/41e01138512f46b6303de95450da209c |
|
| 2022-01-06 10:22:00 |
South Korea HERVaxx Patent Grant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dfedf03e7dbd6429032003642eae36c5 |
|
| 2022-01-06 19:37:00 |
Imugene Receives $6.54 million R&D Tax Incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/da700765444ce8ffd4f323e96ac685fa |
|
| 2022-01-10 17:11:00 |
Release of Securities from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe1274bb04d04d466966ffcbc15bce5e |
|
| 2022-01-14 17:15:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3cd31a8d1662231089f947d80e4df714 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-01-21 10:20:00 |
Retirement of Chief Medical Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f14c878ebab3f5ab9542cf1f82bc7f7b |
Company Administration - Other
|
| 2022-01-21 17:36:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/912d606cb3f12581579f4e59f1ae4816 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-01-28 09:05:00 |
HER-Vaxx Immunotherapy Patent Granted in Europe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/af537160f07be14a7c1eab6ca171e60e |
|
| 2022-01-28 12:07:00 |
PD1-Vaxx Clinical Trial Supply Agreement with Roche |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bd8176be29b51a350bafe33a5a756600 |
|
| 2022-01-28 17:13:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/edc0e38a12c4877a8367108f9d0739a5 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2022-01-31 09:52:00 |
Oncolytic Virotherapy CF33 Patent Granted in Japan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d89860733b976be390aa5df106ceea89 |
|
| 2022-01-31 18:45:00 |
Issue of Options under the Employee Share Option Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d945ac6c34db13032ca19cce957f3801 |
|
| 2022-02-01 08:21:00 |
Appointment of Dr Steven Cha as Chief Medical Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5df99a2a6aea40f4225bdf117aeaf20e |
Company Administration - Other
|
| 2022-02-01 18:28:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69e63778eeaae0c9c3b4311ead4d3e48 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-02-04 17:01:00 |
BPAY or EFT Process for IMUOC & IMUOD Option Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/725903ef642e4482882613f4ba7cdc5b |
Company Administration - Other
|
| 2022-02-04 17:25:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af3b1e6cb52f4305f1c3051bf93fb1c9 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-02-04 17:47:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/180b0ca4f6259eac89e7f9ff25066075 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-02-04 18:07:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ffbb88b088a10ad858322401450fde92 |
|
| 2022-02-07 08:17:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16f3ff0b33e5c2d60509abc9eb6f7519 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-02-09 10:58:00 |
Change of Director's Interest Notice - JE |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa93ec1c799c218129c8bf2c137c08f7 |
Change of Director's Interest Notice
|
| 2022-02-11 16:50:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a58a9c1677640359ce6d34806385f13e |
Appendix 2A (Application for Quotation of Securities
|
| 2022-02-11 17:14:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e76d45dce9337dac4fa10190f34a9e65 |
|
| 2022-02-23 09:17:00 |
Science Series CHECKvacc |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc77357f194e76ddc0846d4d8a71a3d4 |
|
| 2022-02-28 10:07:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b0731f34e461365df227e44684e33804 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2022-03-04 17:49:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8291f26854c601ebe7167d8a87d4e03c |
Appendix 2A (Application for Quotation of Securities
|
| 2022-03-15 08:28:00 |
Imugene HER-Vaxx Clinical Trial Collaboration with Merck |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d0e70367e3b30ae1a210f94a68b1beb9 |
|
| 2022-03-15 09:13:00 |
Investor webinar Imugene & Merck collaboration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/daabd578a757f55ed75943af443f828c |
|
| 2022-03-23 09:54:00 |
Clinical Trial of New Cancer Oncolytic Virotherapy Vaxinia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/897f79a2669207aee843a669042f22bf |
|
| 2022-03-24 09:15:00 |
Dose Escalation in Phase 1 Clinical Trial of CHECKvacc |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00c45a74614c672772de011d9dd3261d |
|
| 2022-04-01 11:53:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e267772410cfcb5c961efd848dcf1e5b |
Appendix 2A (Application for Quotation of Securities
|
| 2022-04-12 10:35:00 |
Release of Securities from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c9de620257430d2e33dd03766e1054a |
|
| 2022-04-13 09:29:00 |
First Cohort 2 Patient Dosed in Clinical Trial of CHECKvacc |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a7f95181673c333039622ca9513e570 |
|
| 2022-04-22 14:23:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a4495cfd906a6b9a3f0376d08584294b |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2022-04-29 14:44:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b00bdf437aa82e5d79238055f1400988 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-05-02 12:37:00 |
Termination of Supply Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72b20007e53a8ffe776551e5569d40a7 |
|
| 2022-05-03 10:01:00 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7e25a6c2ede5541aa160e4bc497e6cf |
|
| 2022-05-03 13:02:00 |
Clarification Announcement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7339bf4c3b02227180fd9184d69a624a |
Company Administration - Other
|
| 2022-05-09 14:02:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9d7dc0056abaf75200d1cc2c47f491c |
|
| 2022-05-10 08:31:00 |
IMU RECEIVES ETHICS APPROVAL TO START HER-VAXX NextHERIZON |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0ae3ef8597bdbca2a2df8af17257b24b |
|
| 2022-05-18 08:22:00 |
IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa7d35a78cf4b4cf0aeefb42de9b6e5c |
|
| 2022-05-23 08:37:00 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99c93bbaed74b739ee7225cbc5cf270e |
|
| 2022-05-27 13:01:00 |
IMUGENE ANNOUNCES PUBLICATION OF ASCO 2022 PD1-VAXX ABSTRACT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f443270d1005008a52ccc8880c64d515 |
|
| 2022-05-31 10:15:00 |
IMUGENE PUBLICATION OF CHECKVACC ABSTRACT AT ASCO 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b3137249243af8eda0e7c54bc730e9c |
|
| 2022-06-01 09:37:00 |
IMUGENE APPOINTS DR YANGHEE WOO TO SCIENTIFIC ADVISORY BOARD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ab1928cb72a6377772779de1ada966d |
Company Administration - Other
|
| 2022-06-08 17:43:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b4b0bc6c00f31271d2769f53a5b61a1 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-06-08 17:48:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2a1de0573bc6d4e3d78d13ff816273a |
|
| 2022-06-09 16:43:00 |
Change of Director's Interest Notice - LR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/47072ef839b374b29ea4a9b3a14cf377 |
Change of Director's Interest Notice
|
| 2022-06-14 09:10:00 |
Change of Director's Interest Notice - CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88eeb499102a60a8cb2b553d6b7cb8b8 |
Change of Director's Interest Notice
|
| 2022-06-27 08:24:00 |
Final HER-Vaxx Phase 2 Trial Overall Survival Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aee361d1f494d3ae4c346d8706b9d16b |
|
| 2022-06-27 09:15:00 |
Investor Webinar - Final HER-Vaxx Overall Survival Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ff7d5d0a71c28509f611163c76f22eb |
|
| 2022-07-01 11:44:00 |
Appointment of Dr Sharon Yavrom as Clinical Scientist |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3472eeb13bdb8f983c917cd5c4f7afa6 |
Company Administration - Other
|
| 2022-07-13 09:30:00 |
IMU to Present New PD1-Vaxx Data at the WCLC 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c65d4abd61d971d75eeec18730b982d2 |
|
| 2022-07-18 09:35:00 |
Imugene appoints experienced life sciences CFO Mike Tonroe |
0 |
https://app.sharelinktechnologies.com/announcement/asx/354d3ab88705391c2504006bdb41b73c |
Company Administration - Other
|
| 2022-07-21 16:36:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e5593263cbf6a430a1e74d1997fddd0 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-07-21 16:48:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1dd11b8971949bc81766651a4c84c89d |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-07-25 11:27:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/689ea4fabae36d266c1efef96d8a7d40 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2022-08-05 16:32:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6fdffc6efae426f9fc35e1135f7b3afe |
Appendix 2A (Application for Quotation of Securities
|
| 2022-08-08 09:06:00 |
Imugene Presents New PD1-Vaxx Data at the 2022 WCLC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0de516da78520fcf428aded7f7fd6d24 |
Company Administration - Other
|
| 2022-08-10 09:18:00 |
FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/92b55f95570edfb644d12d009b839285 |
|
| 2022-08-31 08:09:00 |
Annual Report and Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cdd92ea7097a58d41e4c36d68c464564 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2022-08-31 08:10:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50b53e2419ad9c3d988a6916d64a1b7d |
|
| 2022-08-31 08:11:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26e79a95e1daf67db4b8686d2d853618 |
|
| 2022-08-31 08:18:00 |
Environmental Social and Governance (ESG) Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88a1ef6436af1e87164bfaa8a4490f25 |
|
| 2022-09-01 09:32:00 |
Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ec21a6eac65223ffe2ebd9dd79ae30c |
|
| 2022-09-01 13:02:00 |
Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/78f29543cb07e6e8b804e5cca71de68b |
|
| 2022-09-02 14:59:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d322f0b8ce190c2cc81286f64b550dc5 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-09-07 09:53:00 |
Imugene appoints Dr Jakob Dupont as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4d9e2ca3dfd9cdadf3b500ea9697419 |
Director Appointment/Resignation
|
| 2022-09-07 15:43:00 |
Initial Director's Interest Notice - JD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00bd2a88afa59ce73942c9319f39ae83 |
Initial Director's Interest Notice
|
| 2022-09-07 17:32:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7de7d1cb6b94650ec4f14ad1d9cd7f55 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-09-08 08:54:00 |
Imugene doses first patient in nextHERIZON Phase 2 trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8cd6def9ad68583843a429d3f23f4f8f |
|
| 2022-09-12 09:04:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/85a11cf70d189d7816bac333cbb2f537 |
|
| 2022-09-13 08:54:00 |
IMUGENE ANNOUNCES A$80 MILLION INSTITUTIONAL PLACEMENT |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7461122b5e441296a80ff49accbd54f9 |
|
| 2022-09-13 08:54:00 |
Proposed issue of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4b0aa4c8e3525169083f4b864f592bf |
|
| 2022-09-16 12:21:00 |
Prospectus for the issue of institutional placement options |
1 |
https://app.sharelinktechnologies.com/announcement/asx/142210a50773b0ce4c2f6086796ba685 |
|
| 2022-09-19 09:46:00 |
OGTR grants VAXINIA DIR licence allowing trial expansion |
1 |
https://app.sharelinktechnologies.com/announcement/asx/30c607739dfe123d204d95dc8d929f1d |
|
| 2022-09-19 17:12:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1dd5b288c0d8147f493257f3ef071f7f |
Appendix 2A (Application for Quotation of Securities
|
| 2022-09-19 17:18:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7637deb0dee8379163dfa64ef6596907 |
|
| 2022-09-20 15:54:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4168974a05322f877c427d0ed29749b4 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-09-21 09:29:00 |
First patient IV dosed in VAXINIA Phase 1 clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ef9a4e447e57b89ecfa78ff28f0b0aa |
|
| 2022-09-26 09:55:00 |
Preclinical trial of ALA iNKT therapy and IMU onCARlytics |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ccef481d927c5bc77530e7479a3250aa |
|
| 2022-09-26 10:33:00 |
Investor Presentation Imugene Arovella Therapies |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8aef3f85dcca2e569dfe0f2ded4aeacf |
|
| 2022-09-27 09:01:00 |
ALA iNKT therapy and IMU onCARlytics - correction |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3422642a4a230b2a790145773f083ba4 |
|
| 2022-10-04 08:31:00 |
Imugene appoints Dr Giovanni Selvaggi as CMO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57f0462d2f29fc5b588d1c742da30544 |
Company Administration - Other
|
| 2022-10-04 08:34:00 |
Imugene appoints Paul Wright as Vice President CMC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46799b7f9c8321bebaa81bfbcec6a4a4 |
Company Administration - Other
|
| 2022-10-06 09:28:00 |
onCARlytics to be showcased in three abstracts at SITC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a1cb8d7f49c5d6238f5a135d8a7fc0cb |
Company Administration - Other
|
| 2022-10-07 09:47:00 |
HERIZON study results to be featured at ESMO Asia Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f25a88d62d8cef2313cfad53ee7b707 |
Company Administration - Other
|
| 2022-10-13 17:28:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5dfb405b04b8bd4d0331f1ad95fa76c0 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-10-14 18:32:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b218714ecfa9e160ec0d8e0755af9c98 |
Notice of Annual General Meeting
|
| 2022-10-18 18:02:00 |
ABL and Imugene partner to advance VAXINIA manufacturing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8dd2dd861109e98738e59f228260d364 |
Company Administration - Other
|
| 2022-10-19 17:25:00 |
Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8d7d341a2feecbb7a89d44b2db00c7f |
Alteration to issued capital
|
| 2022-10-19 18:25:00 |
Letter to IMUOC Optionholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb64f116d668ff02c3c3c01dae842bca |
|
| 2022-10-21 16:30:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a89c3ec676377aaf42ae287404fe5e5 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-10-27 17:39:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44c748b1586788b3823694fac9f8fa9f |
Appendix 2A (Application for Quotation of Securities
|
| 2022-10-28 16:48:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cb83e32081e155cee83a36d227fffb77 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2022-10-31 08:45:00 |
First patient dosed in VAXINIA intratumoral cohort 2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72110c55408a547cbff5ff997fdfe81f |
|
| 2022-11-03 16:57:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33dc8f40b27b3559f38a2f1d6f830f96 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-11-03 17:03:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0bf8753b762ab6580ddae4a2e6ecc7ca |
|
| 2022-11-07 10:14:00 |
Europe Patent to be granted for iNKT Cell Therapy Platform |
1 |
https://app.sharelinktechnologies.com/announcement/asx/45001e18bd2e10d5f119b188ac56e811 |
|
| 2022-11-08 11:40:00 |
AGM ATTENDANCE |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ddade83839e4ce9df91438cb977afd7 |
Notice of Meeting - Other
|
| 2022-11-09 09:41:00 |
Change of Director's Interest Notice - JE & CW |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01cf26d01b77645ef916fde7a931534e |
Change of Director's Interest Notice
|
| 2022-11-11 08:47:00 |
Imugene onCARlytics with Celularity CyCART-19 T Cells SITC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1bc0ced3d50a0ed55fe373de06b7bf7d |
Company Administration - Other
|
| 2022-11-11 08:51:00 |
Imugene onCARlytics with blinatumomab SITC presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0ce28b13e3f2cbaa207770f7dfa7e064 |
|
| 2022-11-11 11:04:00 |
Dose escalates In Phase I Clinical Trial of New Oncolytic Vi |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a90702c5aa5f6e23f8a59e7f52913e75 |
|
| 2022-11-11 15:25:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af34ca07466aa617cb2aba41ae65f9a1 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-11-14 09:41:00 |
Imugene onCARlytics with Estrella ARTEMIS T Cells SITC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b241f77f392c86788e287016a195583 |
Company Administration - Other
|
| 2022-11-15 10:15:00 |
Imugene Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eca1352293ab232425c3e0aea7de4d72 |
|
| 2022-11-17 08:56:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f9ab6167750e1a8bb223cc0d3bbec5f7 |
Chairman's Address to Shareholders
|
| 2022-11-17 16:38:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e64586d45377aa4fe41194ee7f55df03 |
|
| 2022-11-18 14:39:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f2b00341a1c1b5efe7a378ad2987c83 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-11-25 16:35:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a04fb06eec9ad61a37d862f86b84d2e8 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-12-05 09:34:00 |
Positive New HER-Vaxx HERIZON Data Presented at ESMO Asia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/433130598e12100824c60cbf0c63a869 |
|
| 2022-12-05 09:40:00 |
First Patient Dosed in VAXINIA Intravenous Cohort 2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ce0bedc62aa4b171ef1f0446c687fea3 |
|
| 2022-12-05 15:52:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a595c14df2b9ba7d208efea960210187 |
Appendix 2A (Application for Quotation of Securities
|
| 2022-12-05 15:53:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7cfd2fa819ab061b28e54a59d4a44ef3 |
|
| 2022-12-06 16:52:00 |
Appendix 3H |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8622ac37cc0528911b203e8fd7340d9 |
Appendix 3H (Notification of cessation of securities)
|
| 2022-12-09 09:25:00 |
CHECKVacc Data Presented at the 2022 SABC Symposium |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c1c9651c28d958644261c1f607ea4120 |
|
| 2022-12-12 11:38:00 |
Imugene to Present at J.P. Morgan Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45e156e7bd694d8c44b8500cacff3c69 |
|
| 2022-12-16 09:53:00 |
Imugene HER-Vaxx and CF33 Platforms To Feature at ASCO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63222b244e65a8f20ec8b09de5552a4b |
|
| 2022-12-16 17:33:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e77ab0cd1dafa1c70e278144114ba944 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-12-16 17:35:00 |
Notification of cessation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c45d2a59586f3ef6ca19d1c9782f2860 |
Appendix 3H (Notification of cessation of securities)
|
| 2022-12-20 13:47:00 |
Change of Director's Interest Notice x6 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a3118025b2890223ea5723d7e07674a |
Change of Director's Interest Notice
|
| 2022-12-20 13:48:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71aea84a92b3d6b25df9fefb7ba20fce |
Ceasing to be a substantial holder
|
| 2022-12-22 14:23:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0b1d57c51dc895b968cc2412cb00a26 |
Ceasing to be a substantial holder
|
| 2022-12-22 15:32:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03f072f5b2698de106bbdabfdb7fb885 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-12-22 15:36:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/504278e5fdf75b6da5779dd361acf370 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2023-01-06 10:28:00 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c404168565d06b56de646713f7eb32ea |
|
| 2023-01-09 09:31:00 |
Imugene Receives Vaxinia Ethics Approval in Australia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/571b35b6128097afe865e0ad8561e0d1 |
|
| 2023-01-09 09:41:00 |
Imugene Presentation to the JP Morgan Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/310797fae73a4d9018ca18995cd8d101 |
|
| 2023-01-20 09:07:00 |
HER-Vaxx and CF33 Platforms Featured at ASCO Symposium |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68eb097611ac32388c08f504eb91225b |
|
| 2023-01-27 09:51:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc07005457a3be022b3e1a09391a4610 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2023-02-02 09:50:00 |
Imugene VAXINIA trial advances to Combination Cohort |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7e7d53a1d1b4cf2fcfa06b4ec3f8a7c2 |
|
| 2023-02-10 08:41:00 |
Imugene PD1-Vaxx Immunotherapy Patent Granted in the US |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e204993ddb6f43f6f406ee142116502 |
|
| 2023-02-22 17:30:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1265eebab512e5f3a97ca23314013c96 |
Appendix 2A (Application for Quotation of Securities
|
| 2023-02-28 12:07:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5c49eba2d27aa25c1988e73c4653570d |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2023-03-02 14:05:00 |
Imugene appoints CFO Mike Tonroe as Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d68f3fc6ce4d334eead09bd82640dcda |
Company Secretary Appointment/Resignation
|
| 2023-03-03 09:41:00 |
First Patients Dosed in Combination Study of VAXINIA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/01934c81c60e4ca10e2f5a73926ad8a3 |
|
| 2023-03-08 09:49:00 |
Change of Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e22ba174d4d5f9d11fe0bc19810434d4 |
Details of Registered office address
|
| 2023-03-10 17:04:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0d7d8854e62208308dbb924072faff7 |
Appendix 2A (Application for Quotation of Securities
|
| 2023-03-10 17:08:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5736e5f629566fe735dbd06f8c06baee |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2023-03-10 17:15:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b7af78086670836271aa3ae1b7bd6589 |
|
| 2023-03-15 11:55:00 |
Imugene Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8e62b642fefc18bab6df318c01ec675 |
|
| 2023-03-16 10:01:00 |
Imugene to present at NWR Virtual Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43811232082c9b5b0ea2013c88fbbc9e |
Company Administration - Other
|
| 2023-03-22 09:47:00 |
Imugene Presentation to NWR Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f7468346ea9308db7c3b204c6aab2b9 |
|
| 2023-04-05 09:35:00 |
First patients dosed in IT & IV cohort 3 of VAXINIA trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/da37c901f6a03f3ce0d3313d9c799f03 |
|
| 2023-04-20 08:33:00 |
Imugene Images and Follows CHECKVacc in TNBC Patients |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2723603ba50289969a04d8d006071330 |
|
| 2023-04-26 09:00:00 |
Imugene receives $12.6m R&D tax refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d4e5cec2770faaac42566a657c2a52c8 |
Company Administration - Other
|
| 2023-04-28 08:18:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b6efab710bf37bad180c962601b9420 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2023-05-03 08:37:00 |
onCARlytics with Artemis T cells abstract presented at ASGCT |
1 |
https://app.sharelinktechnologies.com/announcement/asx/560ccf48ac4bcca9d09985d2370ddf5c |
|
| 2023-05-18 09:04:00 |
onCARlytics with ARTEMIS T cells show anti-tumour activity |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4389898391b6a121d34ef9da4801cc90 |
|
| 2023-05-19 08:35:00 |
FDA clears Imugene IND for onCARlytics first-in-class study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0291aba0e21457feb325a427c7ed4b94 |
|
| 2023-05-19 12:24:00 |
Imugene Investor Webinar - FDA IND Clearance for onCARlytics |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d033ff40b798acfbf53fb78e30c6c70 |
|
| 2023-06-01 09:02:00 |
Imugene doses first combination patient in PD1-Vaxx trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/48738c824cefbbde618b961904e19fda |
|
| 2023-06-09 08:56:00 |
Imugene Advances VAXINIA MAST Trial to Next IV Cohorts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15d0652b0922e766f9095056913b1ac6 |
|
| 2023-06-21 08:25:00 |
Imugene Appoints Kim Drapkin as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83ae6d822cde76d44cffd650098eed1b |
Director Appointment/Resignation
|
| 2023-06-23 16:35:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d160024426bb508e13e6b48184fefdee |
Initial Director's Interest Notice
|
| 2023-06-29 08:39:00 |
Imugene PD1-Vaxx patent extended to 2040 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1189f85f0a1508fabe3072f378cb6299 |
|
| 2023-06-30 08:40:00 |
HER-Vaxx induced antibodies correlated with tumour reduction |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8d3b492bce7b980739c3ae10df35d38b |
Company Administration - Other
|
| 2023-06-30 16:33:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4706042eb0dc8ea4304dc4d51b02d576 |
Change of Director's Interest Notice
|
| 2023-07-06 08:25:00 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/525c624a1c5274e1bcd831fc598f2579 |
|
| 2023-07-07 08:56:00 |
New Dose Escalation in Phase I Clinical Trial of CHECKvacc |
1 |
https://app.sharelinktechnologies.com/announcement/asx/202f8aa9fcea1f26917a97046b22b7e3 |
|
| 2023-07-07 18:29:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/96026fa7eb485dba194303b700a401c8 |
Final Director's Interest Notice
|
| 2023-07-18 15:44:00 |
Roadshow investor webinar with Professor Yuman Fong |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68930485bcce4b1ab5aecf48d6b46d20 |
|
| 2023-07-18 17:05:00 |
Imugene Appoints Dr Weitzman Interim Chief Medical Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18330e2d3341b916b2e19304839b970d |
Company Administration - Other
|
| 2023-07-19 09:51:00 |
Imugene Oncolytic Virotherapy CF33 Patent Allowed in the US |
1 |
https://app.sharelinktechnologies.com/announcement/asx/058d0f723224f747cbef475c814e2b52 |
|
| 2023-07-20 09:46:00 |
Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/55cfdc17b0077468c9656a04142c9451 |
|
| 2023-07-20 15:20:00 |
Imugene Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/763c2128dcb77fefba33951ea788d937 |
|
| 2023-07-21 11:07:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5c4318b4e43773e95a3c9d822d1a1dfd |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2023-07-24 09:47:00 |
Imugene HER-Vaxx and CHECKVacc to be Featured at ESMO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5ab436a6786eb6e776b610463d617cb0 |
|
| 2023-08-03 09:01:00 |
Imugene CF33 Oncolytic Virus Study to be Showcased at SITC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/23b9cb15359d84b83b20b8b8489aed1f |
Company Administration - Other
|
| 2023-08-14 08:50:00 |
Imugene VAXINIA Trial clears Cohort 3 of IT Monotherapy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c196c59405f291494b6c2b7b6f87afe7 |
|
| 2023-08-16 08:43:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9078d8a53fcf705bc30311770eed3375 |
|
| 2023-08-16 09:01:00 |
Imugene Licenses Allogeneic CD19 CAR T Cell Therapy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dc605a25d3f774c845d784ca000740e1 |
|
| 2023-08-18 09:13:00 |
Imugene completes $35M Placement & Launches c.$30M SPP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f7868fe6641f2c3d600e8f04fbd64b25 |
|
| 2023-08-18 09:15:00 |
Proposed issue of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f190cd21b89a43441c6ab3104ae622ac |
|
| 2023-08-18 09:15:00 |
Proposed issue of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/640cff9fd47e64fdb4dec91941332d13 |
|
| 2023-08-18 09:15:00 |
Imugene Capital Raising Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bd14a059f991597927355c3d4bdd8610 |
|
| 2023-08-21 09:12:00 |
Imugene Appoints Dr Bradley Glover as COO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2648060eba2c50dcd67284c4c0683e36 |
Company Administration - Other
|
| 2023-08-21 12:37:00 |
Investor Webinar on Acquisition of License for Azer-cel |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5e03d158914c5d97dc9be039666d8a75 |
|
| 2023-08-25 10:28:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/adf834833fc40f4f46815a18de6db2e4 |
|
| 2023-08-25 10:46:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b40387570d032bd41c1d81346cb536dc |
Appendix 2A (Application for Quotation of Securities
|
| 2023-08-25 10:50:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7887a1fa0a4704ec43534b737f659fd |
|
| 2023-08-25 15:34:00 |
Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9c4f70ede9c6f9301335c9368ad0b50 |
|
| 2023-08-25 15:40:00 |
Placement and Share Purchase Plan Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/91d74db6f8c4a68ae88836b01592f2a0 |
|
| 2023-08-30 17:02:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c006872ec5a1bc4ffc3dbf54ae778c8c |
Notice of Extraordinary General Meeting
|
| 2023-09-01 10:52:00 |
Imugene Appoints Dr John Byon as SVP Clinical Development |
0 |
https://app.sharelinktechnologies.com/announcement/asx/23fd3065411993334c3fe665aa6d5937 |
Company Administration - Other
|
| 2023-09-01 17:02:00 |
S&P DJI Announces September 2023 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a3ca43c9581c243fd6d711a4f3cdce47 |
Standard and Poor's Announcement
|
| 2023-09-04 08:58:00 |
VAXINIA MAST Trial Clears Intratumoral Combination Cohort 1 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8517669556c134c74661bc5b985e4c8e |
|
| 2023-09-04 09:05:00 |
Paul Woodard, M.D. appointed as Chief Medical Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3dd1c12f1fb71a01bf930da348b5e4d4 |
Company Administration - Other
|
| 2023-09-11 08:37:00 |
Imugene Receives Positive Feedback From FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/24721f9b52a62d13cda295b75f21d20d |
|
| 2023-09-12 09:05:00 |
Imugene PD1-Vaxx Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d1ce4af1cbe630bd276531592390780e |
|
| 2023-09-13 17:13:00 |
Share Purchase Plan Closing Date Extended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/10579aeb794f3f699f7f5ec656244189 |
|
| 2023-09-25 09:32:00 |
Imugene Closes SPP Raising $18.2 million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d38a936041ecd237c61dacae18cec44e |
|
| 2023-09-26 11:41:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b0740310fee64ff677b30d56c0a3e62 |
Appendix 2A (Application for Quotation of Securities
|
| 2023-09-28 09:15:00 |
Azer-cel FDA IND Transferred to Imugene |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e435330daeb88eed7b83acbd5c05c790 |
|
| 2023-09-28 09:30:00 |
CEO Presentation to the EGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b24364e1ff90dfb403c0cbda6e08372 |
|
| 2023-09-28 15:51:00 |
Results of Extraordinary General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88be486c79ef5331bb784462f1e19943 |
|
| 2023-09-29 16:19:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45670f0cb06839d5608cf7b2d829a31b |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2023-09-29 16:20:00 |
Preliminary Final Report - Reporting Adjustments |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5d66a72ee0f6832d8450111c06f4be21 |
|
| 2023-09-29 16:32:00 |
Corporate Governance Statement 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8edf4430bbc690107a64a4308f243926 |
|
| 2023-09-29 16:35:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/574529193c68f003eef4117efc173594 |
|
| 2023-09-29 16:36:00 |
Imugene ESG Report 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d77f35072913fb3033556586fbc23e5 |
Sustainability/Climate Action Report
|
| 2023-10-03 11:51:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d5fdd25475b34f2ca3f9b58515e4c66 |
Appendix 2A (Application for Quotation of Securities
|
| 2023-10-03 11:54:00 |
Distribution Schedule and Top 20 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/923cf0780061cbbd069c28040feb8b01 |
|
| 2023-10-03 11:56:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0fadb955be675a74a1d2f03fa2d23cb |
Appendix 2A (Application for Quotation of Securities
|
| 2023-10-03 11:59:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/24fb0a993ce2f719393b60c4fccc3170 |
|
| 2023-10-04 19:08:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9582e49c66de608ac614fc5edfa25e22 |
Change of Director's Interest Notice
|
| 2023-10-04 19:15:00 |
Change of Director's Interest Notice - KD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed6ddce17603c00981988c22fb3b15c9 |
Change of Director's Interest Notice
|
| 2023-10-04 19:15:00 |
Change of Director's Interest Notice - LR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/782411d57e71f4c31bd2f7bbee37fe1c |
Change of Director's Interest Notice
|
| 2023-10-04 19:17:00 |
Change of Director's Interest Notice - JE |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f3001d5cddcabba0c80dba5cbab939f |
Change of Director's Interest Notice
|
| 2023-10-04 19:18:00 |
Change of Director's Interest Notice - JD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ac6c846d84bf0b1e521709cbb051889 |
Change of Director's Interest Notice
|
| 2023-10-04 19:25:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7cfbf0fed09885871649c3c337e278ef |
Change of Director's Interest Notice
|
| 2023-10-11 19:39:00 |
Change of Director's Interest Notice - LC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fdefcb1a89862dff8d0080cafc9b0ec0 |
Change of Director's Interest Notice
|
| 2023-10-12 18:01:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/168b4493a8e73dc7c2ad52592326538b |
Change of Director's Interest Notice
|
| 2023-10-24 09:44:00 |
Imugene B Cell & OV Platforms Featured at ESMO Congress |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53d61bf7689d39ca964ef1bc8805439b |
|
| 2023-10-26 09:08:00 |
Imugene Phase 1 onCARlytics CD19 virus clinical trial opens |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3434a86aa1d3b6326bab485dd6d3bf08 |
|
| 2023-10-30 19:00:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c829bd44a15b9c1dd8fdfea260ca347a |
Notice of Annual General Meeting
|
| 2023-10-31 09:05:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/92445140d229fbbfb8879d08a03459b4 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2023-10-31 18:19:00 |
Amended Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c27db16d9b9b342edef1ffe1de6aff9 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2023-11-02 09:39:00 |
Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/34d3dc1030a10b9a2779b413b9e85c17 |
|
| 2023-11-06 09:54:00 |
Phase 1 CF33 VAXINIA Study Update - Positive Early Signals |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b3ee2babbe9169c14c9713148791610 |
|
| 2023-11-07 13:05:00 |
Imugene Investor Webinar - MAST Study Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db85be032ef59a5060509a089aa3e0a8 |
|
| 2023-11-10 09:03:00 |
Azer-cel Hits Major Milestone in Phase 1b CAR T Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/18b2974b7f362eb24f1f7589d7eb995d |
|
| 2023-11-14 16:38:00 |
Investor Webinar featuring COO, Dr Glover & CMO, Dr Woodard |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d30c5d2349c9920118170310aca2dec4 |
|
| 2023-11-28 08:53:00 |
FDA Fast Track Designation Granted for VAXINIA Trial Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/351be8fca4adc2803016465ac12e83aa |
|
| 2023-11-30 14:03:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/981a5afa5575a10afa84a4e618eea76c |
Chairman's Address to Shareholders
|
| 2023-11-30 17:30:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7ca8faa46a51c16b78f3c13b5213284 |
|
| 2023-12-06 08:50:00 |
Europe Patent to be Granted for PD1-Vaxx Cancer Vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c9053e99bb0602645156602f6b93888c |
|
| 2023-12-06 09:31:00 |
New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3f5f7f37f6498f46edd89dea8d9827b6 |
|
| 2023-12-06 18:32:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/896c65c3402e6ef05849a48e41e67e28 |
Appendix 2A (Application for Quotation of Securities
|
| 2023-12-11 09:01:00 |
Imugene to Present at Annual JPMorgan Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cce3002fc3cdde596ba04a2acf7f71a5 |
|
| 2023-12-12 09:28:00 |
Imugene and NeoImmuneTech to Improve Cancer Treatments |
1 |
https://app.sharelinktechnologies.com/announcement/asx/77e34d325a5cbb251f1e27ce132a6fcc |
|
| 2024-01-10 10:58:00 |
Imugene Presentation to JPMorgan Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d295c1f63c8d942f41356c794c94b43a |
|
| 2024-01-17 09:39:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6170106a1d39e7c949503cc1a3b1675d |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2024-01-17 10:00:00 |
Phase 1 CF33-hNIS Study Update - Positive Early Signals |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e3f08edd0f6ca2f459e8990321a683e9 |
|
| 2024-01-18 09:49:00 |
Update - Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b045b3864d314199db31048a5f725a69 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2024-01-19 10:10:00 |
VAXINIA Phase 1 trial doses patients in higher dose cohorts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c033859ed1c994d3c83c4e5a1af23bb9 |
|
| 2024-01-19 11:22:00 |
Imugene CF33-hNIS (VAXINIA) & MAST Study Featured at ASCO GI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53d9ae29a3060b1cc208649bc7cc73ca |
|
| 2024-01-19 15:46:00 |
Change of Director's Interest Notice x6 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15f4de0d600bccf45502c4e858d2b2e3 |
Change of Director's Interest Notice
|
| 2024-01-31 08:53:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/851cf14202f2d8157ef85475b48aef12 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2024-02-01 12:00:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a19d5dd1be717f72d7b7da2def7467b |
Appendix 2A (Application for Quotation of Securities
|
| 2024-02-01 12:01:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fcbb047cc2ab554948b31b586a5756e2 |
Appendix 2A (Application for Quotation of Securities
|
| 2024-02-01 12:07:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a1122d926a536df7d4625daff4181713 |
|
| 2024-02-01 12:10:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3dfa483799a29e155ba3748d3dacb29a |
Change of Director's Interest Notice
|
| 2024-02-02 18:44:00 |
Notice of change of interests of substantial holder - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6e3c921f0d8d22619530072b580829a2 |
Change in substantial holding
|
| 2024-02-15 08:29:00 |
Phase 1 onCARlytics Trial Doses First Intravenous Patient |
1 |
https://app.sharelinktechnologies.com/announcement/asx/04df782b19a62bd6992287f5db08c872 |
|
| 2024-02-29 08:27:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8475735f04048c1da16786fb17ac8820 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2024-03-11 09:28:00 |
Phase 1 onCARlytics Trial Advances to Combination Arm |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b0f05dc9d1695377ab4a2175af27791 |
|
| 2024-04-02 17:51:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a905d1856412a0d64f586069a37d45a2 |
Appendix 2A (Application for Quotation of Securities
|
| 2024-04-02 17:57:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/86236505fb61400c7f91edc135c36e29 |
|
| 2024-04-03 08:44:00 |
Imugene to present at 2024 Cholangiocarcinoma Conference |
1 |
https://app.sharelinktechnologies.com/announcement/asx/add9148ce9f142bef989318838987d3e |
Company Administration - Other
|
| 2024-04-04 08:41:00 |
Oncolytic Virotherapy CF33 Patent Granted in China |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00780aa2c1acd14d29bbd2ce6a18ca77 |
|
| 2024-04-08 09:00:00 |
VAXINIA and HER-Vaxx featured at the AACR Annual Meeting |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5235e782a8e9a1daf4cb6aaa491a57e9 |
|
| 2024-04-15 08:36:00 |
Bile Tract Cancer Study Opens after MAST High Dose Clearance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f1b5011d624d093aabda185352a4895 |
|
| 2024-04-15 18:25:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64f45601a204d1e3e0638eca110d43ab |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2024-04-15 18:27:00 |
Notification of cessation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/389d5ac5ae3be012e76cf300c5c028ff |
Appendix 3H (Notification of cessation of securities)
|
| 2024-04-16 08:34:00 |
Imugene and Kincell Bio Announce Strategic Partnership |
1 |
https://app.sharelinktechnologies.com/announcement/asx/246a8833433157c3130a50d04a72ec49 |
|
| 2024-04-17 10:31:00 |
Imugene & Kincell Bio Strategic Partnership Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3fa1dd031db5161908948d050b9180c |
|
| 2024-04-19 16:27:00 |
Notification regarding unquoted securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc578d10a7ee8ab3e307cb562e52ec52 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2024-04-23 16:50:00 |
Change of Director's Interest Notice - PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d6e639993c870d3a99d466ca91a91ce |
Change of Director's Interest Notice
|
| 2024-04-30 08:48:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa4a1bde3c610e60908c326c5d9ed588 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2024-05-06 16:10:00 |
Application for quotation of securities - IMU |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a1e6b3e3172b463dea0f5e692efff6cb |
Appendix 2A (Application for Quotation of Securities
|